The field of microfluidics has advanced to the point that it is fulfilling much of its promise to supplant conventional laboratory fluid handling. The ability to precisely control the movement, accession, allocation, and mixing of minute amounts of fluids and subject those fluids to additional processing, analysis, and the like has helped move the field into the mainstream of scientific research, diagnostics, and medical devices.
As research and diagnostic needs become more and more complex, however, there is a need for the field of microfluidics to similarly advance in complexity, requiring a wide range of new functionalities within the microfluidic context. By way of example, microfluidic systems have been used to deliver and combine reagents within microfluidic channels and then perform subsequent processing and/or analytical operations on those reagents, including, e.g., thermal cycling, separations, optical, chemical or electrical detection, and a host of other operations.
In other applications, microfluidic systems have been used to partition small aliquots of aqueous fluids within flowing streams of immiscible fluids, e.g., oils, in order to compartmentalize reactions within those partitions for separate processing, analysis, etc. Specific implementations of these systems have been used to compartmentalize individual nucleic acids in order to perform quantitative amplification and detection reactions (qPCR).
In another implementation, discrete droplets in an emulsion contain both template nucleic acids and beads bearing large numbers of oligonucleotide barcodes, where a given bead will have a constant barcode sequence. The barcode is then used to prime replication of fragments of the template molecules within the particular partition. The replicate fragments created within a given droplet will all share the same barcode sequence, allowing replicate fragments from single long template molecules to be attributed to that longer template. Sequencing of the replicate fragments then provides barcode linked-reads that can be later attributed back to an originating long fragment, provide long range sequence context for shorter sequence reads.
With increasing demands on microfluidic systems, there is a need to add to the microfluidic tools that can be applied to expand their utility. The present disclosure provides a number of such tools and the uses and applications thereof.
The present disclosure provides novel, improved microfluidic structures, systems and methods for carrying out a variety of different fluid manipulations in microscale channel networks for use in a variety of different applications and methods.
In general a microfluidic channel network is provided, including: a first fluid channel having a first depth dimension; at least a second channel intersecting the first channel at a first intersection; at least a third channel in fluid communication with the first intersection, at least one of the first intersection and the third channel having a depth dimension that is greater than the first depth dimension.
In an aspect, the disclosure provides a microfluidic device. The microfluidic comprises a first fluid channel having a first depth dimension; at least a second channel intersecting the first channel at a first intersection; at least a third channel in fluid communication with the first intersection, at least one of the first intersection and the third channel having a depth dimension that is greater than the first depth dimension. In some embodiments, the microfluidic device further comprises a fourth channel segment, fifth channel segment, sixth channel segment and seventh channel segment intersecting the fourth channel segment at a second intersection, the fifth, sixth and seventh channel segments being coplanar, and where a cross sectional dimension of the seventh channel segment perpendicular to the first plane is larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane.
In some embodiments, the microfluidic device further comprises one or more steps disposed within one or more of the fourth and seventh channel segments, where the one or more steps provide the cross sectional dimension of the seventh channel segment that is larger than the cross sectional dimension of the fourth channel segment. In some embodiments, the one or more step increases the cross sectional dimension perpendicular to the first plane by at least 1%.
An additional aspect of the disclosure provides a microfluidic system. The microfluidic system comprises a microfluidic channel network comprising first, second, third and fourth channel segments in fluid communication at a first intersection, the first, second, third and fourth channel segments being coplanar, and where a cross sectional dimension of the fourth channel segment perpendicular to the first plane is larger than a cross sectional dimension of the first channel segment perpendicular to the first plane; and a flow control system for directing a first fluid through the first channel segment into the first intersection and into the fourth channel segment, and directing one or more focusing fluids from the second and third channel segments into the first intersection and into the fourth channel segment.
In some embodiments, the microfluidic system comprises a fifth, sixth and seventh channel segment intersecting the fourth channel segment at a second intersection, the fifth, sixth and seventh channel segments being coplanar, and where a cross sectional dimension of the seventh channel segment perpendicular to the first plane is larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane; and where the flow control system directs the first fluid and focusing fluids and second focusing fluids from the fifth and sixth channel segments into the second intersection. In some embodiments, the first fluid and focusing fluids flow in laminar flow into the fourth channel segment. In some embodiments, the microfluidic system further comprises one or more steps disposed within one or more of the channel segments and providing the larger cross sectional dimensions of the channel segments.
In some embodiments, the one or more step increases the cross sectional dimension perpendicular to the first plane by at least about 1%, at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50% and least about 100%.
In another aspect, this disclosure provides a microfluidic system. The microfluidic system comprises first, second and third channel segments in fluid communication at a first intersection, the first, second, and third channel segments being coplanar, and where a cross sectional dimension of the third channel segment perpendicular to the first plane is larger than a cross sectional dimension of the first channel segment perpendicular to the first plane; and a flow control system for directing a first fluid through the first channel segment into the first intersection and into the fourth channel segment, and directing a second fluid from the second channel segment into the first intersection and into the third channel segment.
In some embodiments, the microfluidic system further comprises a fifth, sixth and seventh channel segment intersecting the fourth channel segment at a second intersection, the fifth, sixth and seventh channel segments being coplanar, and where a cross sectional dimension of the seventh channel segment perpendicular to the first plane is larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane; and where the flow control system directs the first fluid and focusing fluids and second focusing fluids from the fifth and sixth channel segments into the second intersection. In some embodiments, the first fluid and focusing fluids flow in laminar flow into the fourth channel segment.
In another aspect, the present disclosure provides a microfluidic system. The microfluidic system comprises a first channel segment fluidly connecting a source of disruptable particles, with a first droplet forming junction, the first channel segment comprising a constricted region proximal to the droplet forming junction; and a flow control system for driving the disruptable particles through the constricted region, where the constricted region comprises a cross sectional dimension reduced sufficiently to induce disruption of the disruptable particles driven through the constricted region, and for flowing disrupted particles into the droplet formation junction, whereby at last a portion of the disrupted particles or the contents thereof are encapsulated into one or more droplets.
In some embodiments, the microfluidic system further comprises a second channel segment, a third channel segment and a fourth channel segment in fluid communication with the first channel segment, where the second channel segment, third channel segment and fourth channel segment facilitate formation of one or more droplets at the droplet forming junction.
In some embodiments, the microfluidic system further comprises a fifth, sixth and seventh channel segment intersecting the fourth channel segment at a second intersection, the fifth, sixth and seventh channel segments being coplanar, and where a cross sectional dimension of the seventh channel segment perpendicular to the first plane is larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane; and where the flow control system directs the first fluid and focusing fluids and second focusing fluids from the fifth and sixth channel segments into the second intersection. In some embodiments, the first fluid and focusing fluids flow in laminar flow into the fourth channel segment.
In some embodiments, the microfluidic system comprises the constricted region positioned at a distance of fewer than 100 microns, fewer than 50 microns, fewer than 20 microns, fewer than 10 microns or fewer than 5 microns away from the droplet formation junction.
In some embodiments, the present disclosure provides a method of co-partitioning particles using the microfluidic system comprising providing one or more first particle and disrupting the particle by passage through the constriction; providing one or more second particle; and co-partitioning the first and second particle. In some embodiments, the first particle is one or more cells and the second particle is one or more bead. In some embodiments, the first particle is a single cell and the second particle is a single bead. In some embodiments, the bead is a gel bead. In some embodiments, the microfluidic system may further comprise co-partitioning a barcode. In some cases, the barcode is an oligonucleotide. In some cases, the oligonucleotide is a plurality of oligonucleotides having the same sequence. In some embodiments, the method of co-partitioning particles may further comprise providing a lysing agent. In some cases, the method of co-partitioning particles is performed without addition of a lysing agent.
In another aspect, the present disclosure provides a method for controlling filing of a microfluidic network. The method for controlling the filling of a microfluidic network comprises providing a microfluidic channel network comprising a first channel segment and a second channel segment intersecting the first channel segment at a first junction; providing a first fluid in the second channel segment up to the first junction, where capillary flow of the first fluid is interrupted at the first junction; providing a second fluid in the first channel segment, where the second fluid is capable of controlling filling of the microfluidic channel network by releasing the interrupted flow of the first fluid into the microfluidic channel network; and releasing the interrupted flow of the first fluid into the microfluidic channel network.
Some embodiments may provide the method for controlling the filling of a microfluidic network where the first channel segment comprises curved pinning points where the first channel segment meets the first junction. In some cases, the curved pinning points are configured and arranged to provide the interruption of capillary flow of the first fluid. In some embodiments, the method for controlling the filling of a microfluidic network is provided where the microfluidic channel network further comprises a third channel segment at the first junction, where the first fluid and second fluids flow in laminar flow into the third channel segment.
In some embodiments, the second fluid comprises a surfactant. In some embodiments, the surfactant concentration supports release of the interrupted capillary flow of the first fluid upon mixing of the first fluid and the second fluid.
In some embodiments, the microfluidic channel network further comprises one or more additional channel segments intersecting the third channel segment at a second junction, and where the released capillary flow of the first fluid is interrupted at the second junction. In some embodiments, the interruption of capillary flow of the first and second fluids at the second junction is the result of lower surfactant concentration in the mixed first fluid and second fluid. In some embodiments, the method for controlling the filling of a microfluidic network comprises the microfluidic channel network which further comprises a channel expansion feature arranged and configured to control the rate of flow of the first fluid into the microfluidic channel network. In some embodiments, the rate of flow of the first fluid is controlled to be reduced.
In another aspect, the present disclosure provides a method for controlling filing of a microfluidic network. The method for controlling the filling of a microfluidic network comprises providing a microfluidic channel network comprising a first channel segment and a second channel segment intersecting the first channel segment at a first junction; providing a first fluid in the first channel segment up to the first junction, where capillary flow of the first fluid is interrupted at the first junction; providing a second fluid in the second channel segment up to the first junction, where capillary flow of the second fluid is interrupted at the first junction; and providing pressure to both the first and second channel segments to control filling of the microfluidic channel network by releasing the interrupted flow of the first and second fluids into the microfluidic channel network.
In some embodiments, the method for controlling the filling of a microfluidic is where the first channel segment comprises a first curved pinning point and the second channel segment comprises a second curved pinning point where the first and second channel segments meet the first junction. In some cases, the curved pinning points are configured and arranged to provide the interruption of capillary flow of the first and second fluids. In some cases, the first and second curved pinning points each comprise a step feature. In some cases, the step features are configured and arranged to provide a smaller depth at the first junction compared to the depth of the first and second channel segments.
In some embodiments, the microfluidic channel network further comprises a third channel segment at the first junction. In some embodiments, microfluidic channel network further comprises one or more additional channel segments intersecting the third channel segment at a second junction, and where the released flow of the first and second fluids is interrupted at the second junction. In some cases, the method for controlling the filling of a microfluidic network comprises a microfluidic system network further comprising a channel expansion feature arranged and configured to control the rate of flow of the first fluid. In some cases, the rate of flow of the first fluid is reduced.
Additional aspects and advantages of the present disclosure will become readily apparent to those skilled in this art from the following detailed description, wherein only illustrative embodiments of the present disclosure are shown and described. As will be realized, the present disclosure is capable of other and different embodiments, and its several details are capable of modifications in various obvious respects, all without departing from the disclosure. Accordingly, the drawings and description are to be regarded as illustrative in nature, and not as restrictive.
All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference. To the extent publications and patents or patent applications incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material.
The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings (also “Figure” and “FIG.” herein), of which:
While various embodiments of the invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions may occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed.
The term “barcode,” as used herein, generally refers to a label, or identifier, that conveys or is capable of conveying information about an analyte. A barcode can be part of an analyte. A barcode can be a tag attached to an analyte (e.g., nucleic acid molecule) or a combination of the tag in addition to an endogenous characteristic of the analyte (e.g., size of the analyte or end sequence(s)). A barcode may be unique. Barcodes can have a variety of different formats. For example, barcodes can include: polynucleotide barcodes; random nucleic acid and/or amino acid sequences; and synthetic nucleic acid and/or amino acid sequences. A barcode can be attached to an analyte in a reversible or irreversible manner. A barcode can be added to, for example, a fragment of a deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sample before, during, and/or after sequencing of the sample. Barcodes can allow for identification and/or quantification of individual sequencing-reads in real time.
The term “subject,” as used herein, generally refers to an animal, such as a mammal (e.g., human) or avian (e.g., bird), or other organism, such as a plant. The subject can be a vertebrate, a mammal, a mouse, a primate, a simian or a human. Animals may include, but are not limited to, farm animals, sport animals, and pets. A subject can be a healthy or asymptomatic individual, an individual that has or is suspected of having a disease (e.g., cancer) or a pre-disposition to the disease, or an individual that is in need of therapy or suspected of needing therapy. A subject can be a patient.
The term “genome,” as used herein, generally refers to genomic information from a subject, which may be, for example, at least a portion or an entirety of a subject's hereditary information. A genome can be encoded either in DNA or in RNA. A genome can comprise coding regions that code for proteins as well as non-coding regions. A genome can include the sequence of all chromosomes together in an organism. For example, the human genome has a total of 46 chromosomes. The sequence of all of these together may constitute a human genome.
The terms “adaptor(s)”, “adapter(s)” and “tag(s)” may be used synonymously. An adaptor or tag can be coupled to a polynucleotide sequence to be “tagged” by any approach including ligation, hybridization, or other approaches.
The term “sequencing,” as used herein, generally refers to methods and technologies for determining the sequence of nucleotide bases in one or more polynucleotides. The polynucleotides can be, for example, deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), including variants or derivatives thereof (e.g., single stranded DNA). Sequencing can be performed by various systems currently available, such as, without limitation, a sequencing system by Illumina, Pacific Biosciences, Oxford Nanopore, or Life Technologies (Ion Torrent). As an alternative, sequencing may be performed using nucleic acid amplification, polymerase chain reaction (PCR) (e.g., digital PCR, quantitative PCR, or real time PCR) or isothermal amplification. Such devices may provide a plurality of raw genetic data corresponding to the genetic information of a subject (e.g., human), as generated by the device from a sample provided by the subject. In some situations, systems and methods provided herein may be used with proteomic information.
The term “bead,” as used herein, generally refers to a particle. The bead may be a solid or semi-solid particle. The bead may be a gel bead. The bead may be formed of a polymeric material. The bead may be magnetic or non-magnetic.
The term “sample,” as used herein, generally refers to a biological sample of a subject. The biological sample may be a nucleic acid sample or protein sample. The biological sample may be derived from another sample. The sample may be a tissue sample, such as a biopsy, core biopsy, needle aspirate, or fine needle aspirate. The sample may be a fluid sample, such as a blood sample, urine sample, or saliva sample. The sample may be a skin sample. The sample may be a cheek swab. The sample may be a plasma or serum sample. The sample may be a cell-free or cell free sample. A cell-free sample may include extracellular polynucleotides. Extracellular polynucleotides may be isolated from a bodily sample that may be selected from the group consisting of blood, plasma, serum, urine, saliva, mucosal excretions, sputum, stool and tears.
The term “biological particle,” as used herein, generally refers to a discrete biological system derived from a biological sample. The biological particle may be a virus. The biological particle may be a cell or derivative of a cell. The biological particle may be an organelle. The biological particle may be a rare cell from a population of cells. The biological particle may be any type of cell, including without limitation prokaryotic cells, eukaryotic cells, bacterial, fungal, plant, mammalian, or other animal cell types, mycoplasmas, normal tissue cells, tumor cells, or any other cell type, whether derived from single cell or multicellular organisms. The biological particle may be obtained from a tissue of a subject. Biological particles may be disruptable particles.
The biological particle may be a hardened cell. Such hardened cell may or may not include a cell wall or cell membrane. The biological particle may include one or more constituents of a call, but may not include other constituents of the cell. A cell may be a live cell. The live cell may be capable of being cultured, for example, being cultured when enclosed in a gel or polymer matrix, or cultured when comprising a gel or polymer matrix.
The term “macromolecular constituent,” as used herein, generally refers to a macromolecule contained within a biological particle. The macromolecular constituent may comprise a nucleic acid. The macromolecular constituent may comprise deoxyribonucleic acid (DNA). The macromolecular constituent may comprise ribonucleic acid (RNA). The macromolecular constituent may comprise a protein. The macromolecular constituent may comprise a peptide. The macromolecular constituent may comprise a polypeptide.
The term “molecular tag,” as used herein, generally refers to a molecule capable of binding to a macromolecular constituent. The molecular tag may bind to the macromolecular constituent with high affinity. The molecular tag may bind to the macromolecular constituent with high specificity. The molecular tag may comprise a nucleotide sequence. The molecular tag may comprise an oligonucleotide or polypeptide sequence. The molecular tag may comprise a DNA aptamer. The molecular tag may be or comprise a primer. The molecular tag may be or comprise a protein. The molecular tag may comprise a polypeptide. The molecular tag may be a barcode.
The efficiency of many single cell applications can increase by improving cell throughput. For example, this can be achieved by sorting a plurality of droplets that may or may not contain cells and/or particles therein to collect only the droplets that contain the cells and/or particles therein. The isolated population of droplets that contain the cells and/or particles therein can then be subject to further applications, such as nucleic acid amplification and/or sequencing applications.
Microfluidic Structures, Systems and Methods for Droplet Generation
In an aspect, the present disclosure provides a microfluidic channel network. The microfluidic channel network may be used for generating droplets. The droplets may include biological samples and reagents necessary for processing the biological samples. In some examples, the droplets include beads comprising barcodes and biological particles comprising the biological samples, such as, for example, DNA and/or RNA. The biological particles may be cells comprising or enclosed in a gel or polymer matrix.
The microfluidic channel network may include a first fluid channel having a first depth dimension, at least a second channel intersecting the first channel at a first intersection, and at least a third channel in fluid communication with the first intersection. At least one of the first intersection and the third channel may have a depth dimension that is greater than the first depth dimension.
The microfluidic channel network may further comprise fourth channel segments, fifth channel segments, sixth channel segments and seventh channel segments intersecting the fourth channel segment at a second intersection. The fourth, fifth, sixth and seventh channel segments may be coplanar. A cross sectional dimension of the seventh channel segment perpendicular to the first plane may be larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane.
The microfluidic channel network may further comprise one or more steps disposed within one or more of the channel segments. The one or more steps may provide larger cross sectional dimensions of the channels. The one or more steps may increase the cross sectional dimension perpendicular to the first plane by at least about 1%, at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, or at least about 100%. Such increase may be a gradual increase or a steep (or step) increase.
In another aspect, microfluidic system comprises a microfluidic channel network comprising first, second, third and fourth channel segments in fluid communication at a first intersection. The first, second, third and fourth channel segments may be coplanar. A cross sectional dimension of the fourth channel segment perpendicular to the first plane may be larger than a cross sectional dimension of the first channel segment perpendicular to the first plane.
The system may further comprise a flow control system for directing a first fluid through the first channel segment into the first intersection and into the fourth channel segment, and directing one or more focusing fluids from the second and third channel segments into the first intersection and into the fourth channel segment. A focusing fluid may be another aqueous stream or may be non-aqueous (e.g., oil). The flow control system may be or include one or more pumps for providing a negative pressure (e.g., pressure drop) to subject the first fluid to flow. Alternatively, the flow control system may be or include one or more compressors for providing positive pressure to subject a fluid (e.g., the first fluid) to flow.
At least a subset or all of the first, second, third and fourth channel segments may be coplanar (i.e., oriented along the same plane). As an alternative, at least a subset or all of the first, second, third and fourth channel segments may not be coplanar.
The microfluidic system may further comprise a fifth, sixth and seventh channel segment intersecting the fourth channel segment at a second intersection. Such channel segments may be channels or portions of channels. The fifth, sixth and seventh channel segments may be coplanar. A cross sectional dimension of the seventh channel segment perpendicular to the first plane may be larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane.
The microfluidic system may further comprise a flow control system that directs the first fluid and one or more focusing fluids and one or more additional focusing fluids from the fifth and sixth channel segments into the second intersection. The one or more additional focusing fluids may be the same or different from the one or more focusing fluids.
The first fluid and focusing fluids may flow in laminar flow into the fourth channel segment. As an alternative, the first fluid and focusing fluid may flow in turbulent flow into the fourth channel segment.
In another aspect, the microfluidic system may comprise a microfluidic channel network comprising first, second and third channel segments in fluid communication at a first intersection. The first, second, and third channel segments may be coplanar. A cross sectional dimension of the third channel segment perpendicular to the first plane may be larger than a cross sectional dimension of the first channel segment perpendicular to the first plane.
The system may further comprise a flow control system for directing a first fluid through the first channel segment into the first intersection and into the fourth channel segment, and directing a second fluid from the second channel segment into the first intersection and into the third channel segment. The flow control system may be or include one or more pumps for providing a negative pressure (e.g., pressure drop) to subject the first fluid to flow. Alternatively, the flow control system may be or include one or more compressors for providing positive pressure to subject a fluid (e.g., the first fluid) to flow. The microfluidic system may further comprise a fifth, sixth and seventh channel segment intersecting the fourth channel segment at a second intersection. The fifth, sixth and seventh channel segments may be coplanar. A cross sectional dimension of the seventh channel segment perpendicular to the first plane may be larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane.
The microfluidic system may further comprise a flow control system which directs the first fluid and focusing fluids and second focusing fluids from the fifth and sixth channel segments into the second intersection. The first fluid and focusing fluids may flow in laminar flow into the fourth channel segment.
The microfluidic system may further comprise a fifth, sixth and seventh channel segment intersecting the fourth channel segment at a second intersection, the fifth, sixth and seventh channel segments being coplanar and wherein a cross sectional dimension of the seventh channel segment perpendicular to the first plane is larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane; and wherein the flow control system directs the first fluid and focusing fluids and second focusing fluids from the fifth and sixth channel segments into the second intersection.
The first fluid and focusing fluids may flow in laminar flow into the fourth channel segment. Alternatively, the first fluid and focusing fluids may flow in turbulent flow into the fourth channel segment.
The microfluidic channel network may further comprise one or more steps disposed within one or more of the channel segments. The one or more steps may provide larger cross sectional dimensions of the channel segments. The one or more steps may increase the cross sectional dimension perpendicular to the first plane by at least about 1%, at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, or at least about 100%. Such increase may be a gradual increase or a steep (or step) increase.
Reference will now be made to the figures, wherein like numerals refer to like parts throughout. It will be appreciated that the figures and features therein are not necessarily drawn to scale.
In a first example, provided are microfluidic channel networks and systems that provide enhanced partitioning of fluids, e.g., aqueous fluids partitioned as droplets in immiscible oils. For example, in some cases, channel networks may be provided that include a droplet generation junction at the intersection of a first aqueous fluid carrying channel segment and a first partitioning fluid, e.g., oil, carrying channel segment. Typically, aqueous droplets may be formed at the intersection as the aqueous fluid is dripped into the flowing oil stream at the intersection, forming droplets of aqueous fluid within the oil stream.
In operation (and as also illustrated in
Droplets of similar or substantially the same dimensions, e.g., cross section and/or volume, may be repeatedly formed. A number of factors can influence how such droplets are formed, including flow rates of the fluids that are interacting at the droplet generation junction, dimensions of the channels flowing into and out of the intersection, fluid characteristics of the fluids, and interactions between the fluids and the walls of the channels at or near the junction and in the downstream channels.
While certain immiscible phase emulsion arrangements like water in oil are discussed in respect to droplet formation herein, other emulsion arrangements in relation to the systems and methods described herein are envisioned, including but not limited to arrangements of immiscible phases such as air-in-water, oil-in-water, oil-in-water-in-oil, or the likes.
Improved Flow Channel Structures
In some cases, including as illustrated above, droplets being formed at a droplet generation junction have been focused away from the side walls of the channels in which they are flowing by simultaneously flowing the non-aqueous partitioning fluid, e.g., oil, from opposing side channels, e.g., channel segments 106 and 108 in
As described herein, in some cases, the droplet generation junction, e.g.,
As shown in
The step structures described herein may exist at one or both of the upper and/or lower channel walls, and may result in an increase in the depth dimension of the channel, e.g., the dimension perpendicular to the main plane of a device, of at least about 1%, at least about 5%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, and in some cases by at least about 100% or more.
While steps can be provided as structural pinning features, it is envisioned that the same or similar effects can be achieved using a material-based “step”, for example, by patterning sections of channels using a variety of compounds, compositions or even texture. For example, in a channel that has been patterned chemically to form well-defined sections of hydrophilic and hydrophobic surface conditions, an aqueous fluid flowing across a hydrophilic section will pin at an interface with a hydrophobic section.
As the combined fluid is flowed into intersection 308, immiscible partitioning fluid may be introduced from each of side channels 304a and 304b, to further surround the combined fluid stream. This is illustrated in a side view in
Co-Partitioning Channel Networks
In another aspect, microfluidic system is described. The microfluidic system may comprise a first channel segment fluidly connecting a source of disruptable particles, with a first droplet forming junction. The disruptable particles may be a single cell or multiple cells from a biological specimen.
The first channel segment may comprise a constricted region proximal to the droplet forming junction. A flow control system may further drive the disruptable particles through the constricted region. The constricted region may comprise a cross sectional dimension reduced sufficiently to induce disruption of the disruptable particles driven through the constricted region. The disruptable particles may then physically become disrupted, damaged or lysed upon passage through the channel, resulting in a damaged or lysed cell. The flow control system may then be used to flow the disrupted particles into the droplet formation junction, whereby a portion of the disrupted particles or the contents thereof may be encapsulated into one or more droplets.
The microfluidic system may further comprise a second channel segment, a third channel segment and a fourth channel segment in fluid communication with the first channel segment. The second channel segment, third channel segment and fourth channel segment may facilitate the formation of one or more droplets at the droplet forming junction.
The microfluidic system may further comprise fifth channel segments, sixth channel segments and seventh channel segments intersecting the fourth channel segment at a second intersection. The fifth, sixth and seventh channel segments may be coplanar. A cross sectional dimension of the seventh channel segment perpendicular to the first plane may be larger than the cross sectional dimension of the fourth channel segment perpendicular to the first plane. The flow control system may direct the first fluid and focusing fluids and second focusing fluids from the fifth and sixth channel segments into the second intersection.
The first fluid and focusing fluids may flow in laminar flow into the fourth channel segment. As an alternative, the first fluid and focusing fluid may flow in turbulent flow into the fourth channel segment.
The microfluidic system may position the constricted region at a distance fewer than 100 microns, 50 micrometers (microns), 20 microns, 10 microns, 5 microns 1 micron, 0.5 microns, or less away from the droplet formation junction.
In addition, a method of co-partitioning particles is provided using the microfluidic system described above. The method may comprise providing a first particle (e.g., cell from a biological specimen) and disrupting the particle by passaging through the constricted region. The microfluidic system may further provide a second particle (e.g., bead/beads which may contain barcodes and/or other reagents); and co-partitioning the first and second particle in to one/more droplets for further processing of the biological specimen. Alternatively, the first particle may comprise multiple cells. The second particle may also comprise multiple beads to be co-partitioned with the first particle comprising multiple cells.
The microfluidic system may enable co-partitioning the first and the second particle in the microfluidic system, where, the second particle may comprise a gel bead. Additionally, the second particle may comprise a barcode. The barcode may comprise an oligonucleotide. Alternatively, the barcode may comprise a plurality of oligonucleotides having the same sequence. In another embodiment, the first or the second particle may comprise a lysing agent. In yet another embodiment, the method of co-partitioning the first and the second particle may be performed without the addition of a lysing agent.
As shown in
The constriction 402 feature is detailed in
As shown in
Cell Content Analysis
As noted above, in some cases, microfluidic channel networks are particularly desired for use in analyzing the contents of cells, and particularly for evaluation of the contents of individual cells. In certain cases, an individual cell may be partitioned within a single droplet of aqueous fluid in an immiscible partitioning fluid. By co-partitioning a lysis agent, e.g., as described above, along with the cell, one may disrupt the cell and release its contents into the droplet for subsequent processing and/or analysis within the droplet. For example, as described in co-pending U.S. Patent Application Publication No. 2015/0376609, filed on Jun. 26, 2015, which is entirely incorporated herein by reference, an individual cell may be co-partitioned with a lysis agent and a set of oligonucleotide barcodes, as described above. The lysis agent may then act on the cells to release the contents of the cell into the partition. The co-partitioned barcodes may then be used to tag the nucleic acid contents of the cell as described above. Different barcode sequences may be added to different droplets or partitions within the overall emulsion, such that nucleic acids from a given cell will only be tagged with one barcode, allowing more effective attribution of the barcodes, and their connected nucleic acids, to an originating cell, once those nucleic acids and barcodes are sequenced.
In some cases, as shown in and discussed above for
It is worth noting that while the systems and methods disclosed herein are capable of performing cell lysis, even complete cell lysis, it is envisioned and can be understood that modifications to the lysis structures or lysis agent used can result in any desired degree of partial lysis or disruption of the cell, e.g., disruption of a cell membrane. For convenience however, the phrases lysis structure and lysis agent will be used to describe any level of cell disruption.
A particular advantage of the systems and methods disclosed herein includes the ability to lyse a cell, e.g., a single cell, immediately upstream of the droplet generation junction, so one can be more certain that the contents of a given cell will be partitioned within a single droplet (or a small number of droplets). Moreover, because of the laminar flow characteristics of microfluidic systems, one may be reasonably certain that only minimal diffusion of the cellular contents will occur. It is envisioned that minimal diffusion or dispersion of cell contents may be achieved by providing short residence times (the time between lysis and encapsulation for example). In some cases, the lysis structure may be provided within a distance of fewer than 100 microns, fewer than 50 microns, fewer than 20 microns, fewer than 10 microns, fewer than 5 microns away from the droplet generation junction. In other cases, the lysis structure may be provided at a distance that provides for minimal amount of diffusion time for the released contents of a cell between lysis and partitioning within the droplet generation junction at the flow rates used in a given operation. For example, in some cases, this time may be less than about 100 milliseconds (ms), less than about 50 ms, less than about 30 ms, less than about 20 ms, less than about 10 ms, or even less than about 5 ms down to as low as 1 ms, 0.5 ms, 0.1 ms or even less than about 0.01 ms.
In some cases, a lysis structure may include a cross-sectional restricted region of a channel that imparts sufficient shear forces upon a cell or other particle so as to cause its disruption under the conditions being applied, e.g., flow rates, pressures, presence of other lysis reagents, etc. An example of such a structure is illustrated in
In some cases the lysis structure may include a series of constrictions, e.g., at least 2, at least 3, at least 4, at least 5, etc. or more constrictions provided in a series. In other cases the lysis structure may include pillar features arranged in a pathway a cell or cells may traverse and in so doing suffer partial or complete lysis. Combinations of the above lysis structures are also envisioned.
Passive Valving Structures—Aqueous Channels at Intermediate Positions
The present disclosure provides methods for controlling filling of a microfluidic network. A method for controlling filling of a microfluidic channel network may comprise providing a first channel segment and a second channel segment intersecting the first channel segment at a first junction. The first channel segment and second channel segment may be part of a device, such as an integrated device. The device may be a microfluidic device. The device may be a droplet generator. The device may be part of a system. Such system may include a controller for regulating, for example, fluid flow. The system may include one or more pumps and/or one or more compressors (or other actuators) for facilitating fluid flow.
A first fluid may be provided in the second channel segment up to the first junction. In this embodiment the capillary flow of the first fluid may be interrupted at the first junction. A second fluid may also be provided in the first channel segment. The second fluid may be capable of controlling filling of the microfluidic channel network by releasing the interrupted flow of the first fluid into the microfluidic channel network. This may assist in releasing the interrupted flow of the first fluid into the microfluidic channel network.
In some cases, the first channel segment comprises curved or angled pinning points where the first channel segment meets the first junction. Such curved pinning points may be configured and arranged to provide the interruption of capillary flow of the first fluid.
The device may further comprise a third channel segment at the first junction. The first fluid and second fluids may further flow in laminar flow into the third channel segment. Alternatively, the first fluid and second fluids may further flow in turbulent flow in to the third channel.
In some cases, a second fluid comprising a surfactant may be used. The surfactant concentration in the second fluid may be adjusted to support the release of the interrupted capillary flow of the first fluid upon mixing of the first fluid and the second fluid. The interruption of capillary flow of the first and second fluids at the second junction may be the result of a lower surfactant concentration in the mixed first fluid and second fluid. The mixed first and second fluids may be interrupted by either decreased surfactant concentration due to mixing or due to physical pinning of meniscus which may be provided at a step change in channel depth and or channel width.
The microfluidic channel network may further comprise one or more additional channel segments. Such additional channel segments may intersect the third channel segment at a second junction. The released capillary flow of the first fluid may further be interrupted at the second junction.
The device may comprise a microfluidic channel network further comprising a channel expansion feature. This channel expansion feature may be arranged and configured to control the rate of flow of the first fluid into the microfluidic channel network. The channel expansion feature may control the rate of flow of the first fluid. The channel expansion feature may reduce the flow rate of the first fluid. Alternatively, in yet another embodiment, the microfluidic channel expansion may increase the flow rate of the first fluid.
In yet another aspect, a method for controlling filing of a microfluidic network is described. The microfluidic network may comprise providing a microfluidic channel network comprising a first channel segment and a second channel segment intersecting the first channel segment at a first junction. The microfluidic channel network may provide a first fluid in the first channel segment up to the first junction. Capillary flow of the first fluid may be interrupted at the first junction. Additionally, it may provide a second fluid in the second channel segment up to the first junction. Capillary flow of the second fluid may also be interrupted at the first junction. The method may then further include providing pressure to both the first and second channel segments to control the filling of the microfluidic channel network by releasing the interrupted flow of the first and second fluids into the microfluidic channel network.
The microfluidic network may further comprise a first channel segment comprising a first curved pinning point and the second channel segment comprising a second curved pinning point where the first and second channel segments meet the first junction. The curved pinning points in both the first channel segment and the second channel segment may be configured and arranged to provide the interruption of capillary flow of the first and second fluids.
In some cases, the first and second curved pinning points in the first channel segment and the second channel segment respectively may each comprise a step feature. Additionally, the step features may be configured and arranged to provide a smaller depth at the first junction compared to the depth of the first and second channel segments. In some cases, the microfluidic channel network may further comprise a third channel segment at the first junction. These additional channel segments may intersect the third channel segment at a second junction, wherein the released flow of the first and second fluids is interrupted at the second junction.
Some embodiments of this method of controlling the filling of the microfluidic network may further comprise a channel expansion feature. This channel expansion feature may be arranged and configured to control the rate of flow of the first fluid. The channel expansion feature may control the rate of flow of the first fluid. The channel expansion feature may reduce the flow rate of the first fluid. Alternatively, in some cases, the microfluidic channel expansion may increase the flow rate of the first fluid.
As described elsewhere herein, microfluidic channel networks may be used in conjunction with different types of fluids within the same channel network, including different types of aqueous fluids, aqueous and non-aqueous fluids, etc. In such systems, as well as in many other applications of microfluidic systems, it may be desirable to provide stepwise additions of different fluid materials to the channel networks, in order to rely on capillary action and wicking to fill the channels, while only having such filling reach certain portions of the channel network and not others.
In certain cases, microfluidic structures or arrangements may be provided to ensure proper and selective filling of different channel segments. One example of such an arrangement incorporates an intervening passive valving structure disposed between two channel segments in which differential filling is desired. In a simple context, such valving structures may include areas of increased cross sectional dimension disposed at an end of a given channel segment, such that capillary forces can draw fluid into the valving structure. These structures may include step structures that increase the depth of the channel, widened channel regions that increase the lateral cross section of the channels or combinations of these. In some cases, the passive valving may be provided at intersections with connected channel segments, which provide the increased cross sectional area.
Despite the use of these passive valving structures, in many cases, additional measures may be used to prevent fluid wicking beyond a desired point. For example, in certain cases, fluids may be disposed within channel segments that include concentrations of surfactants, e.g., either for partitioning or for use as cell lysis agents. Such surfactant laden fluids can, in some instances, be prone to wicking through microfluidic channel networks despite the presence of passive valves, e.g., by decreasing the contact angle between the fluid and the surface of the channel, resulting in a higher capillary pressure. As such, in using such passive valving structures it may sometimes be desirable to incorporate additional measures to avoid such unintended wicking. In one exemplary approach, an intervening aqueous fluid that may be low in surfactant, e.g., has a higher contact angle than the surfactant laden fluid, may be provided at a passive valving structure. When the surfactant laden fluid reaches the passive valve and adjacent aqueous fluid barrier, the surfactant may be diluted and the contact angle at the interface may be increased such that the passive valve structure functions as desired, preventing further wicking into the channels of the device.
In some cases, additional elements may be incorporated into these intersecting channel segments to allow for segmented introduction of the differing fluids into the device. In some cases, two channel segments in which different filling is desired may be joined at an intersection with a third channel segment. The third channel segment may be first filled with a fluid that will provide a break in the capillary action on one or more fluids introduced into the two other channel segments.
In providing a droplet generation junction within a microfluidic channel network, e.g., as described above, it is generally desirable to provide the non-aqueous fluids in the downstream channels without them wicking into the channels that are to deliver aqueous fluids into the droplet generation junction. Due to the high wettability of non-aqueous fluids on material surfaces, the only way to prevent contamination of the upstream, aqueous fluid-delivering channels with non-aqueous fluid is to fill the desired channels with the aqueous fluids before introducing the non-aqueous fluid. Hydrostatic pressure may then be used to passively balance or counteract the capillary pressure associated with an oil-aqueous or oil-air meniscus.
The pinning point 512 may be configured and arranged, e.g., as curved corners at intersection 513. The radii of curvature may be adjusted to optimize the action of pinning point 512 as desired, the action being in a range from slight to strong restraint of fluid 506 at pinning points 512. Physical or chemical steps may be included within channels or at intersections of channels as required to provide and enable pinning points as described herein. For example, as illustrated in
Physical and chemical steps may be included within channels or at intersections of channels as required to provide and enable pinning points as described herein. For example, as illustrated in
The time required for the menisci to merge may be controlled by the hydrostatic pressure acting on the fluids, by the resistance of the microchannels through which the liquids flow, and/or by the aspect ratio of the channels near the junction. For example, when the channels in which the fluids reside are wider and/or deeper than the channel across which they merge, once pinned at the intersection, the menisci may have a shorter distance to travel before they meet. Wider and/or deeper channels may accommodate greater curvature of the pinned menisci, which may allow them to extend further into the intersection. If the fluids wet the channel surface, decreasing the channel depth in the region shown (the region can also extend further down the channels, up to a point where it starts to increase the resistance of the channels appreciably, which may be undesired when it increases the merging time too much) may generate a stronger capillary pressure in the region, which may accelerate the speeds at which the menisci travel and may cause them to merge faster.
After merging of menisci 604 and 621, the combined fluids 606 and 623 may flow further into the structure 600.
In a further embodiment, stagnation zones that may occur at, for example, pinning points 612 and 621 shown in
Additional features may be included in any of the microfluidic channel networks described herein. Features may include, but are not limited to, constrictions, expansions, steps, coatings, etc. One particularly useful feature is an expansion feature for controlling flow rate. In one embodiment the flow rate may be slowed by inclusion of one or more expansion feature in a given channel or at a junction of channels. The expansion feature may be configured in any of a number of ways but generally is provided as a widening or expansion of a portion of a channel or intersection. The shape of the expansion feature may be regular, irregular, short, elongated, staggered, etc. In one embodiment the expansion feature may be trapezoidal in shape. In another embodiment the expansion feature may be triangular, for example, scalene, isosceles, acute, right, equilateral or obtuse.
Channel networks of the present disclosure may include multiple steps, such as at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 steps. The steps may be oriented in order of increase cross-section.
A channel network of the present disclosure may be disposed in an integrated device, such as a microfluidic device (e.g., a cartridge or chip). Such device may be consumable (e.g., a single-use device, which may be disposed). Alternatively, a channel network of the present disclosure may be disposed in multiple devices. Such devices may be configured to integrate with a system that is configured to, for example, facilitate fluid flow.
In some examples, the radii of curvature may be from about 1×10−8 to 1×10−1 meters (m), from about 1×10−7 to 1×10−2 m, from about 1×10−6 to 1×10−3 m, from about 1×10−6 to 1×10−4 m, or from about 1×10−6 to 1×10−5 m.
Computer Control Systems
The present disclosure provides computer control systems that are programmed to implement methods of the disclosure.
The computer system 801 includes a central processing unit (CPU, also “processor” and “computer processor” herein) 805, which can be a single core or multi core processor, or a plurality of processors for parallel processing. The computer system 801 also includes memory or memory location 810 (e.g., random-access memory, read-only memory, flash memory), electronic storage unit 815 (e.g., hard disk), communication interface 820 (e.g., network adapter) for communicating with one or more other systems, and peripheral devices 825, such as cache, other memory, data storage and/or electronic display adapters. The memory 810, storage unit 815, interface 820 and peripheral devices 825 are in communication with the CPU 805 through a communication bus (solid lines), such as a motherboard. The storage unit 815 can be a data storage unit (or data repository) for storing data. The computer system 801 can be operatively coupled to a computer network (“network”) 830 with the aid of the communication interface 820. The network 830 can be the Internet, an internet and/or extranet, or an intranet and/or extranet that is in communication with the Internet. The network 830 in some cases is a telecommunication and/or data network. The network 830 can include one or more computer servers, which can enable distributed computing, such as cloud computing. The network 830, in some cases with the aid of the computer system 801, can implement a peer-to-peer network, which may enable devices coupled to the computer system 801 to behave as a client or a server.
The CPU 805 can execute a sequence of machine-readable instructions, which can be embodied in a program or software. The instructions may be stored in a memory location, such as the memory 810. The instructions can be directed to the CPU 805, which can subsequently program or otherwise configure the CPU 805 to implement methods of the present disclosure. Examples of operations performed by the CPU 805 can include fetch, decode, execute, and writeback.
The CPU 805 can be part of a circuit, such as an integrated circuit. One or more other components of the system 801 can be included in the circuit. In some cases, the circuit is an application specific integrated circuit (ASIC).
The storage unit 815 can store files, such as drivers, libraries and saved programs. The storage unit 815 can store user data, e.g., user preferences and user programs. The computer system 801 in some cases can include one or more additional data storage units that are external to the computer system 801, such as located on a remote server that is in communication with the computer system 801 through an intranet or the Internet.
The computer system 801 can communicate with one or more remote computer systems through the network 830. For instance, the computer system 801 can communicate with a remote computer system of a user (e.g., technician or researcher). Examples of remote computer systems include personal computers (e.g., portable PC), slate or tablet PC's (e.g., Apple® iPad, Samsung® Galaxy Tab), telephones, Smart phones (e.g., Apple® iPhone, Android-enabled device, Blackberry®), or personal digital assistants. The user can access the computer system 801 via the network 830.
Methods as described herein can be implemented by way of machine (e.g., computer processor) executable code stored on an electronic storage location of the computer system 801, such as, for example, on the memory 810 or electronic storage unit 815. The machine executable or machine readable code can be provided in the form of software. During use, the code can be executed by the processor 805. In some cases, the code can be retrieved from the storage unit 815 and stored on the memory 810 for ready access by the processor 805. In some situations, the electronic storage unit 815 can be precluded, and machine-executable instructions are stored on memory 810.
The code can be pre-compiled and configured for use with a machine having a processer adapted to execute the code, or can be compiled during runtime. The code can be supplied in a programming language that can be selected to enable the code to execute in a pre-compiled or as-compiled fashion.
Aspects of the systems and methods provided herein, such as the computer system 801, can be embodied in programming. Various aspects of the technology may be thought of as “products” or “articles of manufacture” typically in the form of machine (or processor) executable code and/or associated data that is carried on or embodied in a type of machine readable medium. Machine-executable code can be stored on an electronic storage unit, such as memory (e.g., read-only memory, random-access memory, flash memory) or a hard disk. “Storage” type media can include any or all of the tangible memory of the computers, processors or the like, or associated modules thereof, such as various semiconductor memories, tape drives, disk drives and the like, which may provide non-transitory storage at any time for the software programming. All or portions of the software may at times be communicated through the Internet or various other telecommunication networks. Such communications, for example, may enable loading of the software from one computer or processor into another, for example, from a management server or host computer into the computer platform of an application server. Thus, another type of media that may bear the software elements includes optical, electrical and electromagnetic waves, such as used across physical interfaces between local devices, through wired and optical landline networks and over various air-links. The physical elements that carry such waves, such as wired or wireless links, optical links or the like, also may be considered as media bearing the software. As used herein, unless restricted to non-transitory, tangible “storage” media, terms such as computer or machine “readable medium” refer to any medium that participates in providing instructions to a processor for execution.
Hence, a machine readable medium, such as computer-executable code, may take many forms, including but not limited to, a tangible storage medium, a carrier wave medium or physical transmission medium. Non-volatile storage media include, for example, optical or magnetic disks, such as any of the storage devices in any computer(s) or the like, such as may be used to implement the databases, etc. shown in the drawings. Volatile storage media include dynamic memory, such as main memory of such a computer platform. Tangible transmission media include coaxial cables; copper wire and fiber optics, including the wires that comprise a bus within a computer system. Carrier-wave transmission media may take the form of electric or electromagnetic signals, or acoustic or light waves such as those generated during radio frequency (RF) and infrared (IR) data communications. Common forms of computer-readable media therefore include for example: a floppy disk, a flexible disk, hard disk, magnetic tape, any other magnetic medium, a CD-ROM, DVD or DVD-ROM, any other optical medium, punch cards paper tape, any other physical storage medium with patterns of holes, a RAM, a ROM, a PROM and EPROM, a FLASH-EPROM, any other memory chip or cartridge, a carrier wave transporting data or instructions, cables or links transporting such a carrier wave, or any other medium from which a computer may read programming code and/or data. Many of these forms of computer readable media may be involved in carrying one or more sequences of one or more instructions to a processor for execution.
The computer system 801 can include or be in communication with an electronic display 835 that comprises a user interface (UI) 840 for providing, for example, a sample readout, such as results upon assaying a biological sample, or instructions for using systems of the present disclosure to process a biological sample(s). Examples of UI's include, without limitation, a graphical user interface (GUI) and web-based user interface.
Methods and systems of the present disclosure can be implemented by way of one or more algorithms. An algorithm can be implemented by way of software upon execution by the central processing unit 805.
While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. It is not intended that the invention be limited by the specific examples provided within the specification. While the invention has been described with reference to the aforementioned specification, the descriptions and illustrations of the embodiments herein are not meant to be construed in a limiting sense. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. Furthermore, it shall be understood that all aspects of the invention are not limited to the specific depictions, configurations or relative proportions set forth herein which depend upon a variety of conditions and variables. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is therefore contemplated that the invention shall also cover any such alternatives, modifications, variations or equivalents. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
This application claims priority to U.S. Provisional Application No. 62/335,870, filed on May 13, 2016, which is entirely incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2797149 | Skeggs | Jun 1957 | A |
3047367 | Kessler | Jul 1962 | A |
3479141 | Smythe et al. | Nov 1969 | A |
4124638 | Hansen | Nov 1978 | A |
4253846 | Smythe et al. | Mar 1981 | A |
4582802 | Zimmerman et al. | Apr 1986 | A |
5137829 | Nag et al. | Aug 1992 | A |
5149625 | Church et al. | Sep 1992 | A |
5185099 | Delpuech et al. | Feb 1993 | A |
5202231 | Drmanac et al. | Apr 1993 | A |
5270183 | Corbett et al. | Dec 1993 | A |
5413924 | Kosak et al. | May 1995 | A |
5418149 | Gelfand et al. | May 1995 | A |
5436130 | Mathies et al. | Jul 1995 | A |
5478893 | Ghosh et al. | Dec 1995 | A |
5489523 | Mathur | Feb 1996 | A |
5512131 | Kumar et al. | Apr 1996 | A |
5558071 | Ward et al. | Sep 1996 | A |
5585069 | Zanzucchi et al. | Dec 1996 | A |
5587128 | Wilding et al. | Dec 1996 | A |
5605793 | Stemmer | Feb 1997 | A |
5618711 | Gelfand et al. | Apr 1997 | A |
5658548 | Padhye et al. | Aug 1997 | A |
5695940 | Drmanac et al. | Dec 1997 | A |
5700642 | Monforte et al. | Dec 1997 | A |
5705628 | Hawkins | Jan 1998 | A |
5708153 | Dower et al. | Jan 1998 | A |
5736330 | Fulton | Apr 1998 | A |
5739036 | Parris | Apr 1998 | A |
5744311 | Fraiser et al. | Apr 1998 | A |
5756334 | Perler et al. | May 1998 | A |
5834197 | Parton | Nov 1998 | A |
5842787 | Kopf-Sill et al. | Dec 1998 | A |
5846719 | Brenner et al. | Dec 1998 | A |
5846727 | Soper et al. | Dec 1998 | A |
5851769 | Gray et al. | Dec 1998 | A |
5856174 | Lipshutz et al. | Jan 1999 | A |
5872010 | Karger et al. | Feb 1999 | A |
5897783 | Howe et al. | Apr 1999 | A |
5900481 | Lough et al. | May 1999 | A |
5942609 | Hunkapiller et al. | Aug 1999 | A |
5958703 | Dower et al. | Sep 1999 | A |
5965443 | Reznikoff et al. | Oct 1999 | A |
5989402 | Chow et al. | Nov 1999 | A |
5994056 | Higuchi | Nov 1999 | A |
5997636 | Gamarnik et al. | Dec 1999 | A |
6033880 | Haff et al. | Mar 2000 | A |
6046003 | Mandecki | Apr 2000 | A |
6051377 | Mandecki | Apr 2000 | A |
6057107 | Fulton | May 2000 | A |
6057149 | Burns et al. | May 2000 | A |
6103537 | Ullman et al. | Aug 2000 | A |
6133436 | Koster et al. | Oct 2000 | A |
6143496 | Brown et al. | Nov 2000 | A |
6159717 | Savakis et al. | Dec 2000 | A |
6171850 | Nagle et al. | Jan 2001 | B1 |
6172218 | Brenner | Jan 2001 | B1 |
6207384 | Mekalanos et al. | Mar 2001 | B1 |
6258571 | Chumakov et al. | Jul 2001 | B1 |
6265552 | Schatz | Jul 2001 | B1 |
6281254 | Nakajima et al. | Aug 2001 | B1 |
6291243 | Fogarty et al. | Sep 2001 | B1 |
6294385 | Goryshin et al. | Sep 2001 | B1 |
6296020 | McNeely et al. | Oct 2001 | B1 |
6297006 | Drmanac et al. | Oct 2001 | B1 |
6297017 | Schmidt et al. | Oct 2001 | B1 |
6303343 | Kopf-Sill | Oct 2001 | B1 |
6306590 | Mehta et al. | Oct 2001 | B1 |
6327410 | Walt et al. | Dec 2001 | B1 |
6355198 | Kim et al. | Mar 2002 | B1 |
6361950 | Mandecki | Mar 2002 | B1 |
6372813 | Johnson et al. | Apr 2002 | B1 |
6379929 | Burns et al. | Apr 2002 | B1 |
6406848 | Bridgham et al. | Jun 2002 | B1 |
6409832 | Weigl et al. | Jun 2002 | B2 |
6432290 | Harrison et al. | Aug 2002 | B1 |
6432360 | Church | Aug 2002 | B1 |
6481453 | O'Connor et al. | Nov 2002 | B1 |
6485944 | Church et al. | Nov 2002 | B1 |
6492118 | Abrams et al. | Dec 2002 | B1 |
6503757 | Chow | Jan 2003 | B1 |
6511803 | Church et al. | Jan 2003 | B1 |
6524456 | Ramsey et al. | Feb 2003 | B1 |
6569631 | Pantoliano et al. | May 2003 | B1 |
6579851 | Goeke et al. | Jun 2003 | B2 |
6586176 | Trnovsky et al. | Jul 2003 | B1 |
6593113 | Tenkanen et al. | Jul 2003 | B1 |
6613752 | Kay et al. | Sep 2003 | B2 |
6632606 | Ullman et al. | Oct 2003 | B1 |
6632655 | Mehta et al. | Oct 2003 | B1 |
6670133 | Knapp et al. | Dec 2003 | B2 |
6723513 | Lexow | Apr 2004 | B2 |
6767731 | Hannah | Jul 2004 | B2 |
6800298 | Burdick et al. | Oct 2004 | B1 |
6806052 | Bridgham et al. | Oct 2004 | B2 |
6806058 | Jesperson et al. | Oct 2004 | B2 |
6859570 | Walt et al. | Feb 2005 | B2 |
6880576 | Karp et al. | Apr 2005 | B2 |
6884788 | Bulpitt et al. | Apr 2005 | B2 |
6913935 | Thomas | Jul 2005 | B1 |
6929859 | Chandler et al. | Aug 2005 | B2 |
6969488 | Bridgham et al. | Nov 2005 | B2 |
6974669 | Mirkin et al. | Dec 2005 | B2 |
7041481 | Anderson et al. | May 2006 | B2 |
7115400 | Adessi et al. | Oct 2006 | B1 |
7129091 | Ismagilov et al. | Oct 2006 | B2 |
7138267 | Jendrisak et al. | Nov 2006 | B1 |
7211654 | Gao et al. | May 2007 | B2 |
7268167 | Higuchi et al. | Sep 2007 | B2 |
7282370 | Bridgham et al. | Oct 2007 | B2 |
7294503 | Quake et al. | Nov 2007 | B2 |
7297485 | Bornarth et al. | Nov 2007 | B2 |
7316903 | Yanagihara et al. | Jan 2008 | B2 |
7323305 | Leamon et al. | Jan 2008 | B2 |
7329493 | Chou et al. | Feb 2008 | B2 |
7425431 | Church et al. | Sep 2008 | B2 |
7536928 | Kazuno | May 2009 | B2 |
7544473 | Brenner | Jun 2009 | B2 |
7604938 | Takahashi et al. | Oct 2009 | B2 |
7608434 | Reznikoff et al. | Oct 2009 | B2 |
7608451 | Cooper et al. | Oct 2009 | B2 |
7622280 | Holliger et al. | Nov 2009 | B2 |
7638276 | Griffiths et al. | Dec 2009 | B2 |
7645596 | Williams et al. | Jan 2010 | B2 |
7666664 | Sarofim et al. | Feb 2010 | B2 |
7700325 | Cantor et al. | Apr 2010 | B2 |
7708949 | Stone et al. | May 2010 | B2 |
7709197 | Drmanac | May 2010 | B2 |
7745178 | Dong | Jun 2010 | B2 |
7745218 | Kim et al. | Jun 2010 | B2 |
7776927 | Chu et al. | Aug 2010 | B2 |
RE41780 | Anderson et al. | Sep 2010 | E |
7799553 | Mathies et al. | Sep 2010 | B2 |
7842457 | Berka et al. | Nov 2010 | B2 |
7901891 | Drmanac | Mar 2011 | B2 |
7910354 | Drmanac et al. | Mar 2011 | B2 |
7943671 | Herminghaus et al. | May 2011 | B2 |
7947477 | Schroeder | May 2011 | B2 |
7960104 | Drmanac et al. | Jun 2011 | B2 |
7968287 | Griffiths et al. | Jun 2011 | B2 |
7972778 | Brown et al. | Jul 2011 | B2 |
8003312 | Krutzik et al. | Aug 2011 | B2 |
8008018 | Quake et al. | Aug 2011 | B2 |
8053192 | Bignell et al. | Nov 2011 | B2 |
8067159 | Brown et al. | Nov 2011 | B2 |
8101346 | Takahama | Jan 2012 | B2 |
8124404 | Alphey | Feb 2012 | B2 |
8133719 | Drmanac et al. | Mar 2012 | B2 |
8137563 | Ma et al. | Mar 2012 | B2 |
8168385 | Brenner | May 2012 | B2 |
8252539 | Quake et al. | Aug 2012 | B2 |
8268564 | Roth et al. | Sep 2012 | B2 |
8273573 | Ismagilov et al. | Sep 2012 | B2 |
8278071 | Brown et al. | Oct 2012 | B2 |
8298767 | Brenner et al. | Oct 2012 | B2 |
8304193 | Ismagilov et al. | Nov 2012 | B2 |
8318433 | Brenner | Nov 2012 | B2 |
8318460 | Cantor et al. | Nov 2012 | B2 |
8329407 | Ismagilov et al. | Dec 2012 | B2 |
8337778 | Stone et al. | Dec 2012 | B2 |
8361299 | Sabin et al. | Jan 2013 | B2 |
8420386 | Ivics et al. | Apr 2013 | B2 |
8461129 | Bolduc et al. | Jun 2013 | B2 |
8563274 | Brenner et al. | Oct 2013 | B2 |
8592150 | Drmanac et al. | Nov 2013 | B2 |
8598328 | Koga et al. | Dec 2013 | B2 |
8603749 | Gillevet | Dec 2013 | B2 |
8679756 | Brenner et al. | Mar 2014 | B1 |
8748094 | Weitz et al. | Jun 2014 | B2 |
8748102 | Berka et al. | Jun 2014 | B2 |
8765380 | Berka et al. | Jul 2014 | B2 |
8822148 | Ismagliov et al. | Sep 2014 | B2 |
8829171 | Steemers et al. | Sep 2014 | B2 |
8835358 | Fodor et al. | Sep 2014 | B2 |
8871444 | Griffiths et al. | Oct 2014 | B2 |
8889083 | Ismagilov et al. | Nov 2014 | B2 |
8927218 | Forsyth | Jan 2015 | B2 |
8975302 | Light et al. | Mar 2015 | B2 |
8986286 | Tanghoej et al. | Mar 2015 | B2 |
9005935 | Belyaev | Apr 2015 | B2 |
9012390 | Holtze et al. | Apr 2015 | B2 |
9017948 | Agresti et al. | Apr 2015 | B2 |
9029083 | Griffiths et al. | May 2015 | B2 |
9029085 | Agresti et al. | May 2015 | B2 |
9068210 | Agresti et al. | Jun 2015 | B2 |
9074251 | Steemers et al. | Jul 2015 | B2 |
9080211 | Grunenwald et al. | Jul 2015 | B2 |
9089844 | Hiddessen et al. | Jul 2015 | B2 |
9102980 | Brenner et al. | Aug 2015 | B2 |
9126160 | Ness et al. | Sep 2015 | B2 |
9133009 | Baroud et al. | Sep 2015 | B2 |
9150916 | Christen et al. | Oct 2015 | B2 |
9175295 | Kaminaka et al. | Nov 2015 | B2 |
9238671 | Goryshin et al. | Jan 2016 | B2 |
9249460 | Pushkarev et al. | Feb 2016 | B2 |
9273349 | Nguyen et al. | Mar 2016 | B2 |
9290808 | Fodor et al. | Mar 2016 | B2 |
9328382 | Drmanac et al. | May 2016 | B2 |
9347059 | Saxonov | May 2016 | B2 |
9388465 | Hindson et al. | Jul 2016 | B2 |
9410201 | Hindson et al. | Aug 2016 | B2 |
9500664 | Ness et al. | Nov 2016 | B2 |
9567631 | Hindson et al. | Feb 2017 | B2 |
9574226 | Gormley et al. | Feb 2017 | B2 |
9636682 | Hiddessen et al. | May 2017 | B2 |
9637799 | Fan et al. | May 2017 | B2 |
9644204 | Hindson et al. | May 2017 | B2 |
9649635 | Hiddessen et al. | May 2017 | B2 |
9689024 | Hindson et al. | Jun 2017 | B2 |
9694361 | Bharadwaj et al. | Jul 2017 | B2 |
9695468 | Hindson et al. | Jul 2017 | B2 |
9701998 | Hindson et al. | Jul 2017 | B2 |
9856530 | Hindson et al. | Jan 2018 | B2 |
9951386 | Hindson et al. | Apr 2018 | B2 |
9957558 | Leamon et al. | May 2018 | B2 |
9975122 | Masquelier et al. | May 2018 | B2 |
10011872 | Belgrader et al. | Jul 2018 | B1 |
10030267 | Hindson et al. | Jul 2018 | B2 |
10041116 | Hindson et al. | Aug 2018 | B2 |
10053723 | Hindson et al. | Aug 2018 | B2 |
10059989 | Giresi et al. | Aug 2018 | B2 |
10071377 | Bharadwaj et al. | Sep 2018 | B2 |
10137449 | Bharadwaj et al. | Nov 2018 | B2 |
10150117 | Bharadwaj et al. | Dec 2018 | B2 |
10221442 | Hindson et al. | Mar 2019 | B2 |
10245587 | Masquelier et al. | Apr 2019 | B2 |
11084036 | Bharadwaj et al. | Aug 2021 | B2 |
20010020588 | Adourian et al. | Sep 2001 | A1 |
20010036669 | Jedrzejewski et al. | Nov 2001 | A1 |
20010041357 | Fouillet et al. | Nov 2001 | A1 |
20010044109 | Mandecki | Nov 2001 | A1 |
20010048900 | Bardell et al. | Dec 2001 | A1 |
20010052460 | Chien et al. | Dec 2001 | A1 |
20010053519 | Fodor et al. | Dec 2001 | A1 |
20020001856 | Chow et al. | Jan 2002 | A1 |
20020003001 | Weigl et al. | Jan 2002 | A1 |
20020005354 | Spence et al. | Jan 2002 | A1 |
20020034737 | Drmanac | Mar 2002 | A1 |
20020043463 | Shenderov | Apr 2002 | A1 |
20020051971 | Stuelpnagel et al. | May 2002 | A1 |
20020051992 | Bridgham et al. | May 2002 | A1 |
20020058332 | Quake et al. | May 2002 | A1 |
20020065609 | Ashby | May 2002 | A1 |
20020068278 | Giese et al. | Jun 2002 | A1 |
20020089100 | Kawasaki | Jul 2002 | A1 |
20020092767 | Bjornson et al. | Jul 2002 | A1 |
20020113009 | O'Connor et al. | Aug 2002 | A1 |
20020119455 | Chan | Aug 2002 | A1 |
20020119536 | Stern | Aug 2002 | A1 |
20020131147 | Paolini et al. | Sep 2002 | A1 |
20020160518 | Hayenga et al. | Oct 2002 | A1 |
20020164820 | Brown | Nov 2002 | A1 |
20020166582 | O'Connor et al. | Nov 2002 | A1 |
20020172965 | Kamb et al. | Nov 2002 | A1 |
20020175079 | Christel et al. | Nov 2002 | A1 |
20020179849 | Maher et al. | Dec 2002 | A1 |
20020182118 | Perry | Dec 2002 | A1 |
20030005967 | Karp | Jan 2003 | A1 |
20030007898 | Bohm et al. | Jan 2003 | A1 |
20030008285 | Fischer | Jan 2003 | A1 |
20030008323 | Ravkin et al. | Jan 2003 | A1 |
20030022231 | Wangh et al. | Jan 2003 | A1 |
20030027203 | Fields | Feb 2003 | A1 |
20030027214 | Kamb | Feb 2003 | A1 |
20030027221 | Scott et al. | Feb 2003 | A1 |
20030028981 | Chandler et al. | Feb 2003 | A1 |
20030032141 | Nguyen et al. | Feb 2003 | A1 |
20030036206 | Chien et al. | Feb 2003 | A1 |
20030039978 | Hannah | Feb 2003 | A1 |
20030044777 | Beattie | Mar 2003 | A1 |
20030044836 | Levine et al. | Mar 2003 | A1 |
20030075446 | Culbertson et al. | Apr 2003 | A1 |
20030082587 | Seul et al. | May 2003 | A1 |
20030089605 | Timperman | May 2003 | A1 |
20030104466 | Knapp et al. | Jun 2003 | A1 |
20030108897 | Drmanac | Jun 2003 | A1 |
20030124509 | Kenis et al. | Jul 2003 | A1 |
20030149307 | Hai et al. | Aug 2003 | A1 |
20030170698 | Gascoyne et al. | Sep 2003 | A1 |
20030182068 | Battersby et al. | Sep 2003 | A1 |
20030207260 | Trnovsky et al. | Nov 2003 | A1 |
20030215862 | Parce et al. | Nov 2003 | A1 |
20040021068 | Staats | Feb 2004 | A1 |
20040040851 | Karger et al. | Mar 2004 | A1 |
20040063138 | McGinnis et al. | Apr 2004 | A1 |
20040081962 | Chen et al. | Apr 2004 | A1 |
20040101680 | Barber | May 2004 | A1 |
20040101880 | Rozwadowski et al. | May 2004 | A1 |
20040132122 | Banerjee et al. | Jul 2004 | A1 |
20040195728 | Slomski et al. | Oct 2004 | A1 |
20040214175 | McKernan et al. | Oct 2004 | A9 |
20040224331 | Cantor et al. | Nov 2004 | A1 |
20040228770 | Gandhi et al. | Nov 2004 | A1 |
20040258701 | Dominowski et al. | Dec 2004 | A1 |
20050019839 | Jespersen et al. | Jan 2005 | A1 |
20050042625 | Schmidt et al. | Feb 2005 | A1 |
20050079510 | Berka et al. | Apr 2005 | A1 |
20050130188 | Walt et al. | Jun 2005 | A1 |
20050172476 | Stone et al. | Aug 2005 | A1 |
20050181379 | Su et al. | Aug 2005 | A1 |
20050202429 | Trau et al. | Sep 2005 | A1 |
20050202489 | Cho et al. | Sep 2005 | A1 |
20050221339 | Griffiths et al. | Oct 2005 | A1 |
20050244850 | Huang et al. | Nov 2005 | A1 |
20050266582 | Modlin et al. | Dec 2005 | A1 |
20050272159 | Ismagilov et al. | Dec 2005 | A1 |
20050287572 | Mathies et al. | Dec 2005 | A1 |
20060002890 | Hersel et al. | Jan 2006 | A1 |
20060008799 | Cai et al. | Jan 2006 | A1 |
20060020371 | Ham et al. | Jan 2006 | A1 |
20060040382 | Heffron et al. | Feb 2006 | A1 |
20060073487 | Oliver et al. | Apr 2006 | A1 |
20060078888 | Griffiths et al. | Apr 2006 | A1 |
20060094108 | Yoder et al. | May 2006 | A1 |
20060153924 | Griffiths et al. | Jul 2006 | A1 |
20060163070 | Boronkay et al. | Jul 2006 | A1 |
20060163385 | Link et al. | Jul 2006 | A1 |
20060177832 | Brenner | Aug 2006 | A1 |
20060177833 | Brenner | Aug 2006 | A1 |
20060199193 | Koo et al. | Sep 2006 | A1 |
20060240506 | Kushmaro et al. | Oct 2006 | A1 |
20060257893 | Takahashi et al. | Nov 2006 | A1 |
20060263888 | Fritz et al. | Nov 2006 | A1 |
20060275782 | Gunderson et al. | Dec 2006 | A1 |
20060286570 | Rowlen et al. | Dec 2006 | A1 |
20060292583 | Schneider et al. | Dec 2006 | A1 |
20070003442 | Link et al. | Jan 2007 | A1 |
20070020617 | Trnovsky et al. | Jan 2007 | A1 |
20070020640 | McCloskey et al. | Jan 2007 | A1 |
20070031829 | Yasuno et al. | Feb 2007 | A1 |
20070039866 | Schroeder et al. | Feb 2007 | A1 |
20070042400 | Choi et al. | Feb 2007 | A1 |
20070042419 | Barany et al. | Feb 2007 | A1 |
20070054119 | Garstecki et al. | Mar 2007 | A1 |
20070072208 | Drmanac | Mar 2007 | A1 |
20070077572 | Tawfik et al. | Apr 2007 | A1 |
20070092914 | Griffiths et al. | Apr 2007 | A1 |
20070099208 | Drmanac et al. | May 2007 | A1 |
20070134277 | Chen et al. | Jun 2007 | A1 |
20070154903 | Marla et al. | Jul 2007 | A1 |
20070160503 | Sethu et al. | Jul 2007 | A1 |
20070172873 | Brenner et al. | Jul 2007 | A1 |
20070190543 | Livak | Aug 2007 | A1 |
20070195127 | Ahn et al. | Aug 2007 | A1 |
20070207060 | Zou et al. | Sep 2007 | A1 |
20070228588 | Noritomi et al. | Oct 2007 | A1 |
20070231823 | McKernan et al. | Oct 2007 | A1 |
20070238113 | Kanda et al. | Oct 2007 | A1 |
20070242111 | Pamula et al. | Oct 2007 | A1 |
20070259357 | Brenner | Nov 2007 | A1 |
20070264320 | Lee et al. | Nov 2007 | A1 |
20080003142 | Link et al. | Jan 2008 | A1 |
20080004436 | Tawfik et al. | Jan 2008 | A1 |
20080014589 | Link et al. | Jan 2008 | A1 |
20080056948 | Dale et al. | Mar 2008 | A1 |
20080124726 | Monforte | May 2008 | A1 |
20080138878 | Kubu et al. | Jun 2008 | A1 |
20080166720 | Hsieh et al. | Jul 2008 | A1 |
20080213766 | Brown et al. | Sep 2008 | A1 |
20080228268 | Shannon et al. | Sep 2008 | A1 |
20080230386 | Srinivasan et al. | Sep 2008 | A1 |
20080241820 | Krutzik et al. | Oct 2008 | A1 |
20080242560 | Gunderson et al. | Oct 2008 | A1 |
20080268450 | Nam et al. | Oct 2008 | A1 |
20090005252 | Drmanac et al. | Jan 2009 | A1 |
20090011943 | Drmanac et al. | Jan 2009 | A1 |
20090012187 | Chu et al. | Jan 2009 | A1 |
20090025277 | Takanashi | Jan 2009 | A1 |
20090035770 | Mathies et al. | Feb 2009 | A1 |
20090047713 | Handique | Feb 2009 | A1 |
20090048124 | Leamon et al. | Feb 2009 | A1 |
20090053169 | Castillo et al. | Feb 2009 | A1 |
20090068170 | Weitz et al. | Mar 2009 | A1 |
20090098555 | Roth et al. | Apr 2009 | A1 |
20090099041 | Church et al. | Apr 2009 | A1 |
20090105959 | Braverman et al. | Apr 2009 | A1 |
20090118488 | Drmanac et al. | May 2009 | A1 |
20090134027 | Jary | May 2009 | A1 |
20090137404 | Drmanac et al. | May 2009 | A1 |
20090137414 | Drmanac et al. | May 2009 | A1 |
20090143244 | Bridgham et al. | Jun 2009 | A1 |
20090148961 | Luchini et al. | Jun 2009 | A1 |
20090155780 | Xiao et al. | Jun 2009 | A1 |
20090155781 | Drmanac et al. | Jun 2009 | A1 |
20090197248 | Griffiths et al. | Aug 2009 | A1 |
20090197772 | Griffiths et al. | Aug 2009 | A1 |
20090202984 | Cantor | Aug 2009 | A1 |
20090203531 | Kurn | Aug 2009 | A1 |
20090208548 | Mason et al. | Aug 2009 | A1 |
20090264299 | Drmanac et al. | Oct 2009 | A1 |
20090269248 | Falb et al. | Oct 2009 | A1 |
20090286687 | Dressman et al. | Nov 2009 | A1 |
20090311713 | Pollack et al. | Dec 2009 | A1 |
20090320930 | Zeng et al. | Dec 2009 | A1 |
20100021973 | Makarov et al. | Jan 2010 | A1 |
20100021984 | Edd et al. | Jan 2010 | A1 |
20100022414 | Link et al. | Jan 2010 | A1 |
20100029014 | Wang | Feb 2010 | A1 |
20100035254 | Williams | Feb 2010 | A1 |
20100062494 | Church et al. | Mar 2010 | A1 |
20100069263 | Shendure et al. | Mar 2010 | A1 |
20100086914 | Bentley et al. | Apr 2010 | A1 |
20100105112 | Holtze et al. | Apr 2010 | A1 |
20100113296 | Myerson | May 2010 | A1 |
20100120098 | Grunenwald et al. | May 2010 | A1 |
20100130369 | Shenderov et al. | May 2010 | A1 |
20100136544 | Agresti et al. | Jun 2010 | A1 |
20100137163 | Link et al. | Jun 2010 | A1 |
20100173394 | Colston, Jr. et al. | Jul 2010 | A1 |
20100184928 | Kumacheva | Jul 2010 | A1 |
20100187705 | Lee et al. | Jul 2010 | A1 |
20100210479 | Griffiths et al. | Aug 2010 | A1 |
20100248237 | Froehlich et al. | Sep 2010 | A1 |
20100248991 | Roesler et al. | Sep 2010 | A1 |
20100304982 | Hinz et al. | Dec 2010 | A1 |
20110000560 | Miller et al. | Jan 2011 | A1 |
20110008775 | Gao et al. | Jan 2011 | A1 |
20110028412 | Cappello et al. | Feb 2011 | A1 |
20110033548 | Lai et al. | Feb 2011 | A1 |
20110033854 | Drmanac et al. | Feb 2011 | A1 |
20110046243 | Ito et al. | Feb 2011 | A1 |
20110053798 | Hindson et al. | Mar 2011 | A1 |
20110059556 | Strey et al. | Mar 2011 | A1 |
20110071053 | Drmanac et al. | Mar 2011 | A1 |
20110086780 | Colston, Jr. et al. | Apr 2011 | A1 |
20110092376 | Colston, Jr. et al. | Apr 2011 | A1 |
20110092392 | Colston, Jr. et al. | Apr 2011 | A1 |
20110118139 | Mehta | May 2011 | A1 |
20110160078 | Fodor et al. | Jun 2011 | A1 |
20110195496 | Muraguchi et al. | Aug 2011 | A1 |
20110201526 | Berka et al. | Aug 2011 | A1 |
20110217736 | Hindson | Sep 2011 | A1 |
20110218123 | Weitz et al. | Sep 2011 | A1 |
20110263457 | Krutzik et al. | Oct 2011 | A1 |
20110267457 | Weitz et al. | Nov 2011 | A1 |
20110281736 | Drmanac et al. | Nov 2011 | A1 |
20110281738 | Drmanac et al. | Nov 2011 | A1 |
20110287435 | Grunenwald et al. | Nov 2011 | A1 |
20110305761 | Shum et al. | Dec 2011 | A1 |
20110306141 | Bronchetti et al. | Dec 2011 | A1 |
20110319281 | Drmanac | Dec 2011 | A1 |
20120000777 | Garrell et al. | Jan 2012 | A1 |
20120003657 | Myllykangas et al. | Jan 2012 | A1 |
20120010098 | Griffiths et al. | Jan 2012 | A1 |
20120010107 | Griffiths et al. | Jan 2012 | A1 |
20120014977 | Furihata et al. | Jan 2012 | A1 |
20120015382 | Weitz et al. | Jan 2012 | A1 |
20120015822 | Weitz et al. | Jan 2012 | A1 |
20120071331 | Casbon et al. | Mar 2012 | A1 |
20120121481 | Romanowsky et al. | May 2012 | A1 |
20120132288 | Weitz et al. | May 2012 | A1 |
20120135893 | Drmanac et al. | May 2012 | A1 |
20120165219 | Van Der Zaag et al. | Jun 2012 | A1 |
20120172259 | Rigatti et al. | Jul 2012 | A1 |
20120190032 | Ness et al. | Jul 2012 | A1 |
20120190037 | Durin et al. | Jul 2012 | A1 |
20120196288 | Beer | Aug 2012 | A1 |
20120208705 | Steemers et al. | Aug 2012 | A1 |
20120208724 | Steemers et al. | Aug 2012 | A1 |
20120211084 | Weitz et al. | Aug 2012 | A1 |
20120220494 | Samuels et al. | Aug 2012 | A1 |
20120220497 | Jacobson et al. | Aug 2012 | A1 |
20120222748 | Weitz et al. | Sep 2012 | A1 |
20120231972 | Golyshin et al. | Sep 2012 | A1 |
20120252012 | Armougom et al. | Oct 2012 | A1 |
20120253689 | Rogan | Oct 2012 | A1 |
20120297493 | Cooper et al. | Nov 2012 | A1 |
20120309002 | Link | Dec 2012 | A1 |
20120316074 | Saxonov | Dec 2012 | A1 |
20120328488 | Puntambekar et al. | Dec 2012 | A1 |
20130017978 | Kavanagh et al. | Jan 2013 | A1 |
20130018970 | Woundy et al. | Jan 2013 | A1 |
20130022682 | Lee et al. | Jan 2013 | A1 |
20130028812 | Prieto et al. | Jan 2013 | A1 |
20130041004 | Drager et al. | Feb 2013 | A1 |
20130046030 | Rotem et al. | Feb 2013 | A1 |
20130059310 | Brenner et al. | Mar 2013 | A1 |
20130078638 | Berka et al. | Mar 2013 | A1 |
20130079231 | Pushkarev et al. | Mar 2013 | A1 |
20130084243 | Goetsch et al. | Apr 2013 | A1 |
20130096073 | Sidelman | Apr 2013 | A1 |
20130109575 | Kleinschmidt et al. | May 2013 | A1 |
20130109576 | Shuber et al. | May 2013 | A1 |
20130121893 | Delamarche et al. | May 2013 | A1 |
20130130919 | Chen et al. | May 2013 | A1 |
20130157870 | Pushkarev et al. | Jun 2013 | A1 |
20130157899 | Adler, Jr. et al. | Jun 2013 | A1 |
20130178368 | Griffiths et al. | Jul 2013 | A1 |
20130189700 | So et al. | Jul 2013 | A1 |
20130203605 | Shendure et al. | Aug 2013 | A1 |
20130203675 | DeSimone et al. | Aug 2013 | A1 |
20130210639 | Link et al. | Aug 2013 | A1 |
20130210991 | Fonnum et al. | Aug 2013 | A1 |
20130211055 | Raines et al. | Aug 2013 | A1 |
20130225418 | Watson | Aug 2013 | A1 |
20130225623 | Buxbaum et al. | Aug 2013 | A1 |
20130274117 | Church et al. | Oct 2013 | A1 |
20130293246 | Pollack et al. | Nov 2013 | A1 |
20130296173 | Callow et al. | Nov 2013 | A1 |
20130343317 | Etemad et al. | Dec 2013 | A1 |
20140024023 | Cauley, III et al. | Jan 2014 | A1 |
20140030350 | Ashrafi et al. | Jan 2014 | A1 |
20140037514 | Stone et al. | Feb 2014 | A1 |
20140038178 | Otto et al. | Feb 2014 | A1 |
20140057799 | Johnson et al. | Feb 2014 | A1 |
20140065234 | Shum et al. | Mar 2014 | A1 |
20140093916 | Belyaev | Apr 2014 | A1 |
20140120529 | Andersen et al. | May 2014 | A1 |
20140155274 | Xie et al. | Jun 2014 | A1 |
20140155295 | Hindson et al. | Jun 2014 | A1 |
20140194323 | Gillevet | Jul 2014 | A1 |
20140199730 | Agresti et al. | Jul 2014 | A1 |
20140199731 | Agresti et al. | Jul 2014 | A1 |
20140206554 | Hindson et al. | Jul 2014 | A1 |
20140227684 | Hindson et al. | Aug 2014 | A1 |
20140227706 | Kato et al. | Aug 2014 | A1 |
20140228255 | Hindson et al. | Aug 2014 | A1 |
20140235506 | Hindson et al. | Aug 2014 | A1 |
20140242664 | Zhang et al. | Aug 2014 | A1 |
20140274740 | Srinivasan et al. | Sep 2014 | A1 |
20140287963 | Hindson et al. | Sep 2014 | A1 |
20140302503 | Lowe et al. | Oct 2014 | A1 |
20140315725 | Faham et al. | Oct 2014 | A1 |
20140315755 | Chen et al. | Oct 2014 | A1 |
20140357500 | Vigneault et al. | Dec 2014 | A1 |
20140378322 | Hindson et al. | Dec 2014 | A1 |
20140378345 | Hindson et al. | Dec 2014 | A1 |
20140378349 | Hindson et al. | Dec 2014 | A1 |
20140378350 | Hindson et al. | Dec 2014 | A1 |
20150005188 | Levner et al. | Jan 2015 | A1 |
20150005199 | Hindson et al. | Jan 2015 | A1 |
20150005200 | Hindson et al. | Jan 2015 | A1 |
20150011430 | Saxonov | Jan 2015 | A1 |
20150011432 | Saxonov | Jan 2015 | A1 |
20150057163 | Rotem et al. | Feb 2015 | A1 |
20150072899 | Ward et al. | Mar 2015 | A1 |
20150111256 | Church et al. | Apr 2015 | A1 |
20150111788 | Fernandez et al. | Apr 2015 | A1 |
20150119280 | Srinivas et al. | Apr 2015 | A1 |
20150184127 | White | Jul 2015 | A1 |
20150218633 | Hindson et al. | Aug 2015 | A1 |
20150224466 | Hindson et al. | Aug 2015 | A1 |
20150225777 | Hindson et al. | Aug 2015 | A1 |
20150258543 | Baroud et al. | Sep 2015 | A1 |
20150259736 | Steemers et al. | Sep 2015 | A1 |
20150267191 | Steelman et al. | Sep 2015 | A1 |
20150267246 | Baroud et al. | Sep 2015 | A1 |
20150291942 | Gloeckner et al. | Oct 2015 | A1 |
20150298091 | Weitz et al. | Oct 2015 | A1 |
20150299772 | Zhang | Oct 2015 | A1 |
20150299784 | Fan et al. | Oct 2015 | A1 |
20150329891 | Tan et al. | Nov 2015 | A1 |
20150337298 | Xi et al. | Nov 2015 | A1 |
20150353999 | Agresti et al. | Dec 2015 | A1 |
20150361418 | Reed | Dec 2015 | A1 |
20150368638 | Steemers et al. | Dec 2015 | A1 |
20150376605 | Jarosz et al. | Dec 2015 | A1 |
20150376608 | Kaper et al. | Dec 2015 | A1 |
20150376609 | Hindson et al. | Dec 2015 | A1 |
20150376700 | Schnall-Levin et al. | Dec 2015 | A1 |
20150379196 | Schnall-Levin et al. | Dec 2015 | A1 |
20160024558 | Hardenbol et al. | Jan 2016 | A1 |
20160032282 | Vigneault et al. | Feb 2016 | A1 |
20160053253 | Salathia et al. | Feb 2016 | A1 |
20160060621 | Agresti et al. | Mar 2016 | A1 |
20160115474 | Jelinek et al. | Apr 2016 | A1 |
20160122753 | Mikkelsen et al. | May 2016 | A1 |
20160122817 | Jarosz et al. | May 2016 | A1 |
20160123858 | Kapur et al. | May 2016 | A1 |
20160153005 | Zhang et al. | Jun 2016 | A1 |
20160160235 | Solodushko et al. | Jun 2016 | A1 |
20160177359 | Ukanis et al. | Jun 2016 | A1 |
20160208323 | Bernstein et al. | Jul 2016 | A1 |
20160231324 | Zhao et al. | Aug 2016 | A1 |
20160244742 | Linnarsson et al. | Aug 2016 | A1 |
20160244809 | Belgrader et al. | Aug 2016 | A1 |
20160244825 | Vigneault et al. | Aug 2016 | A1 |
20160257984 | Hardenbol et al. | Sep 2016 | A1 |
20160281160 | Jarosz et al. | Sep 2016 | A1 |
20160304860 | Hindson et al. | Oct 2016 | A1 |
20160326583 | Johnson et al. | Nov 2016 | A1 |
20160348093 | Price et al. | Dec 2016 | A1 |
20160376663 | Brown | Dec 2016 | A1 |
20170009274 | Abate et al. | Jan 2017 | A1 |
20170016041 | Greenfield et al. | Jan 2017 | A1 |
20170114390 | Hindson et al. | Apr 2017 | A1 |
20170145476 | Ryvkin et al. | May 2017 | A1 |
20170183701 | Agresti et al. | Jun 2017 | A1 |
20170247757 | Hindson et al. | Aug 2017 | A1 |
20170260584 | Zheng et al. | Sep 2017 | A1 |
20170268056 | Vigneault et al. | Sep 2017 | A1 |
20170321252 | Hindson et al. | Nov 2017 | A1 |
20170348691 | Bharadwaj et al. | Dec 2017 | A1 |
20170356027 | Hindson et al. | Dec 2017 | A1 |
20180008984 | Bharadwaj et al. | Jan 2018 | A1 |
20180015472 | Bharadwaj et al. | Jan 2018 | A1 |
20180015473 | Bharadwaj et al. | Jan 2018 | A1 |
20180016634 | Hindson et al. | Jan 2018 | A1 |
20180030512 | Hindson et al. | Feb 2018 | A1 |
20180030515 | Regev et al. | Feb 2018 | A1 |
20180051321 | Hindson et al. | Feb 2018 | A1 |
20180057868 | Walder et al. | Mar 2018 | A1 |
20180087050 | Zheng et al. | Mar 2018 | A1 |
20180094298 | Hindson et al. | Apr 2018 | A1 |
20180094313 | Hindson et al. | Apr 2018 | A1 |
20180094315 | Hindson et al. | Apr 2018 | A1 |
20180105808 | Mikkelsen et al. | Apr 2018 | A1 |
20180112253 | Hindson et al. | Apr 2018 | A1 |
20180112266 | Hindson et al. | Apr 2018 | A1 |
20180179580 | Hindson et al. | Jun 2018 | A1 |
20180195112 | Lebofsky et al. | Jul 2018 | A1 |
20180216162 | Belhocine et al. | Aug 2018 | A1 |
20180236443 | Masquelier et al. | Aug 2018 | A1 |
20180258466 | Hindson et al. | Sep 2018 | A1 |
20180258482 | Hindson et al. | Sep 2018 | A1 |
20180265928 | Schnall-Levin et al. | Sep 2018 | A1 |
20180273933 | Gunderson et al. | Sep 2018 | A1 |
20180274027 | Hindson et al. | Sep 2018 | A1 |
20180282804 | Hindson et al. | Oct 2018 | A1 |
20180327839 | Hindson et al. | Nov 2018 | A1 |
20180340939 | Gaublomme et al. | Nov 2018 | A1 |
20190134629 | Bernate et al. | May 2019 | A1 |
Number | Date | Country |
---|---|---|
102292455 | Dec 2011 | CN |
103202812 | Jul 2013 | CN |
0249007 | Dec 1987 | EP |
0271281 | Jun 1988 | EP |
0637996 | Jul 1997 | EP |
1019496 | Sep 2004 | EP |
1672064 | Jun 2006 | EP |
1482036 | Oct 2007 | EP |
1841879 | Oct 2007 | EP |
1594980 | Nov 2009 | EP |
1967592 | Apr 2010 | EP |
2258846 | Dec 2010 | EP |
2145955 | Feb 2012 | EP |
1905828 | Aug 2012 | EP |
2136786 | Oct 2012 | EP |
1908832 | Dec 2012 | EP |
2540389 | Jan 2013 | EP |
2635679 | Sep 2013 | EP |
2752664 | Jul 2014 | EP |
2097692 | May 1985 | GB |
2485850 | May 2012 | GB |
S5949832 | Mar 1984 | JP |
S60227826 | Nov 1985 | JP |
2006-507921 | Mar 2006 | JP |
2006-289250 | Oct 2006 | JP |
2007-015990 | Jan 2007 | JP |
2007-268350 | Oct 2007 | JP |
2009-513948 | Apr 2009 | JP |
2009-208074 | Sep 2009 | JP |
2012-131798 | Jul 2012 | JP |
WO-8402000 | May 1984 | WO |
WO-9418218 | Aug 1994 | WO |
WO-9419101 | Sep 1994 | WO |
WO-9423699 | Oct 1994 | WO |
WO-9530782 | Nov 1995 | WO |
WO-9629629 | Sep 1996 | WO |
WO-9641011 | Dec 1996 | WO |
WO-9802237 | Jan 1998 | WO |
WO-9852691 | Nov 1998 | WO |
WO-9909217 | Feb 1999 | WO |
WO-9952708 | Oct 1999 | WO |
WO-2000008212 | Feb 2000 | WO |
WO-0023181 | Apr 2000 | WO |
WO-0026412 | May 2000 | WO |
WO-0043766 | Jul 2000 | WO |
WO-0070095 | Nov 2000 | WO |
WO-0102850 | Jan 2001 | WO |
WO-0114589 | Mar 2001 | WO |
WO-0189787 | Nov 2001 | WO |
WO-0190418 | Nov 2001 | WO |
WO-0127610 | Mar 2002 | WO |
WO-0231203 | Apr 2002 | WO |
WO-02086148 | Oct 2002 | WO |
WO-0218949 | Jan 2003 | WO |
WO-03062462 | Jul 2003 | WO |
WO-2004002627 | Jan 2004 | WO |
WO-2004010106 | Jan 2004 | WO |
WO-2004061083 | Jul 2004 | WO |
WO-2004065617 | Aug 2004 | WO |
WO-2004069849 | Aug 2004 | WO |
WO-2004091763 | Oct 2004 | WO |
WO-2004102204 | Nov 2004 | WO |
WO-2004103565 | Dec 2004 | WO |
WO-2004105734 | Dec 2004 | WO |
WO-2005002730 | Jan 2005 | WO |
WO-2005021151 | Mar 2005 | WO |
WO-2005023331 | Mar 2005 | WO |
WO-2005040406 | May 2005 | WO |
WO-2005049787 | Jun 2005 | WO |
WO-2005082098 | Sep 2005 | WO |
WO-2006030993 | Mar 2006 | WO |
WO-2006078841 | Jul 2006 | WO |
WO-2006096571 | Sep 2006 | WO |
WO-2007001448 | Jan 2007 | WO |
WO-2007002490 | Jan 2007 | WO |
WO-2007012638 | Feb 2007 | WO |
WO-2007018601 | Feb 2007 | WO |
WO-2007024840 | Mar 2007 | WO |
WO-2007081387 | Jul 2007 | WO |
WO-2007084192 | Jul 2007 | WO |
WO-2007089541 | Aug 2007 | WO |
WO-2007093819 | Aug 2007 | WO |
WO-2007111937 | Oct 2007 | WO |
WO-2007114794 | Oct 2007 | WO |
WO-2007121489 | Oct 2007 | WO |
WO-2007133710 | Nov 2007 | WO |
WO-2007138178 | Dec 2007 | WO |
WO-2007139766 | Dec 2007 | WO |
WO-2007140015 | Dec 2007 | WO |
WO-2007147079 | Dec 2007 | WO |
WO-2007149432 | Dec 2007 | WO |
WO-2008021123 | Feb 2008 | WO |
WO-2008091792 | Jul 2008 | WO |
WO-2008102057 | Aug 2008 | WO |
WO-2008121342 | Oct 2008 | WO |
WO-2007081385 | Nov 2008 | WO |
WO-2008061193 | Nov 2008 | WO |
WO-2008109176 | Nov 2008 | WO |
WO-2008134153 | Nov 2008 | WO |
WO-2008150432 | Dec 2008 | WO |
WO-2009005680 | Jan 2009 | WO |
WO-2009011808 | Jan 2009 | WO |
WO-2009015296 | Jan 2009 | WO |
WO-2009048532 | Apr 2009 | WO |
WO-2009061372 | May 2009 | WO |
WO-2009085215 | Jul 2009 | WO |
WO-2009147386 | Dec 2009 | WO |
WO-2010004018 | Jan 2010 | WO |
WO-2010014604 | Feb 2010 | WO |
WO-2010033200 | Mar 2010 | WO |
WO-2010048605 | Apr 2010 | WO |
WO-2010104604 | Sep 2010 | WO |
WO-2010115154 | Oct 2010 | WO |
WO-2010148039 | Dec 2010 | WO |
WO-2010151776 | Dec 2010 | WO |
WO-2010117620 | Feb 2011 | WO |
WO-2011028539 | Mar 2011 | WO |
WO-2011047870 | Apr 2011 | WO |
WO-2011056546 | May 2011 | WO |
WO-2011074960 | Jun 2011 | WO |
WO-2011140627 | Nov 2011 | WO |
WO-2012012037 | Jan 2012 | WO |
WO-2012019765 | Feb 2012 | WO |
WO-2012047889 | Apr 2012 | WO |
WO-2012048340 | Apr 2012 | WO |
WO-2012048341 | Apr 2012 | WO |
WO-2012061832 | May 2012 | WO |
WO-2011066476 | Aug 2012 | WO |
WO-2012106546 | Aug 2012 | WO |
WO-2012112804 | Aug 2012 | WO |
WO-2012112970 | Aug 2012 | WO |
WO-2012083225 | Sep 2012 | WO |
WO-2012136734 | Oct 2012 | WO |
WO-2012142611 | Oct 2012 | WO |
WO-2012148497 | Nov 2012 | WO |
WO-2012149042 | Nov 2012 | WO |
WO-2012166425 | Dec 2012 | WO |
WO-2013019751 | Feb 2013 | WO |
WO-2013036929 | Mar 2013 | WO |
WO-2013055955 | Apr 2013 | WO |
WO-2013096643 | Jun 2013 | WO |
WO-2013122996 | Aug 2013 | WO |
WO-2013123125 | Aug 2013 | WO |
WO-2013126741 | Aug 2013 | WO |
WO-2013134261 | Sep 2013 | WO |
WO-2013150083 | Oct 2013 | WO |
WO-2013177220 | Nov 2013 | WO |
WO-2013188872 | Dec 2013 | WO |
WO-2014028537 | Feb 2014 | WO |
WO-2014053854 | Apr 2014 | WO |
WO-2014071361 | May 2014 | WO |
WO-2014074611 | May 2014 | WO |
WO-2014093676 | Jun 2014 | WO |
WO-2014108810 | Jul 2014 | WO |
WO-2014140309 | Sep 2014 | WO |
WO-2014144495 | Sep 2014 | WO |
WO-2014150931 | Sep 2014 | WO |
WO-2014182835 | Nov 2014 | WO |
WO-2014189957 | Nov 2014 | WO |
WO-2014210353 | Dec 2014 | WO |
WO-2015031691 | Mar 2015 | WO |
WO-2015044428 | Apr 2015 | WO |
WO-2015164212 | Oct 2015 | WO |
WO-2016040476 | Mar 2016 | WO |
WO-2016061517 | Apr 2016 | WO |
WO-2016126871 | Aug 2016 | WO |
WO-2016170126 | Oct 2016 | WO |
WO-2016176322 | Nov 2016 | WO |
WO-2016187717 | Dec 2016 | WO |
WO-2016191618 | Dec 2016 | WO |
WO-2016207647 | Dec 2016 | WO |
WO-2016207653 | Dec 2016 | WO |
WO-2016207661 | Dec 2016 | WO |
WO-2017015075 | Jan 2017 | WO |
WO-2017025594 | Feb 2017 | WO |
WO-2017053902 | Mar 2017 | WO |
WO-2017053903 | Mar 2017 | WO |
WO-2017053905 | Mar 2017 | WO |
WO-2017075265 | May 2017 | WO |
WO-2017156336 | Sep 2017 | WO |
WO-2018045186 | Mar 2018 | WO |
WO-2018119301 | Jun 2018 | WO |
WO-2018191701 | Oct 2018 | WO |
WO-2019028166 | Feb 2019 | WO |
Entry |
---|
Ahn et al., “Electrocoalescence of drops synchronized by size-dependent flow in microfluidic channels,” Appl Phys Lett. 88: 264105-1-264105-3 (2006). |
“How many species of bacteria are there” (wisegeek.com; accessed Jan. 21, 2014). |
Huebner et al., “Microdroplets: A sea of applications?” Lab on a Chip. 8: 1244-1254 (2008). |
Kiss et al., “High-Throughput Quantitative Polymerase Chain Reaction in Picoliter Droplets,” Anal Chem. 80(23): 8975-8981 (2008). |
“List of sequenced bacterial genomes” (Wikipedia.com; accessed Jan. 24, 2014). |
Pascaline et al., “Controlling droplet incubation using close-packed plug flow,” Biomicrofluidics. 5: 024101-1-024101-6 (2011). |
“Portable Water Filters” (http://www.portablewaterfilters.org/water-filter-guide/particle- contaminant-size-chart-microns/) 2015, accessed Oct. 19, 2017. |
“U.S. Appl. No. 61/982,001, filed Apr. 21, 2014 (Year:2014)”. |
10x Genomics. “10x Genomics Chromium™ Single Cell 3′ Solution Utilized for Perturb-seq Approach,” Press Release, <https://www.10xgenomics.com/news/10x-genomics-chromium-single-cell-3-solution-utilized-perturb-seq-approach/>, dated Dec. 19, 2016. |
Abate et al., “Syringe-vacuum microfluidics: A portable technique to create monodisperse emulsions,” Biomicrofluidics. 5(1): 014107 (2011). |
Abate et al., “Valve-based flow focusing for drop formation,” Appl Phys Lett. 94 (2009) (3 pages). |
Abate et al., “Beating Poisson encapsulation statistics using close-packed ordering,” Lab Chip. 9(18):2628-31 (2009). |
Abate et al., “High-throughput injection with microfluidics using picoinjectors,” Proc Natl Acad Sci USA. 107(45):19163-6 (2010). |
Adamson et al., “Production of arrays of chemically distinct nanolitre plugs via repeated splitting in microfluidic devices,” Lab Chip. 6(9): 1178-1186 (2006). |
Adamson et al., “A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response,” Cell. 167(7):1867-1882.e21 (2016). |
Adey et al. “Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition,” Genome Biology. 11:R119 (2010). |
Adey et al., “Ultra-low-input, tagmentation-based whole-genome bisulfite sequencing,” Genome Research. 22(6): 1139-1143 (2012). |
Agresti et al., “Selection of Ribozymes that Catalyse Multiple-Turnover Diels-Alder Cycloadditions by Using in Vitro Compartmentalization,” Proc Natl Acad Sci U S A. 102(45):16170-5 (2005). |
Agresti et al., “Ultra-high-throughput screening in drop-based microfluidics for directed evolution,” Proc Natl Acad Sci USA. 107(9): 4004-9 (2010). |
Ahern, “Biochemical, Reagents Kits Offer Scientists Good Return on Investment,” The Scientist.9(15):1-7 (1995). |
Ahn et al., “Dielectrophoretic manipulation of drops for high-speed microfluidic sorting devices,” Applied Physics Letter. 88 (2006). |
Aitman et al., “Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans,” Nature. 439(7078):851-5 (2006). |
Akselband, “Enrichment of slow-growing marine microorganisms from mixed cultures using gel microdrop (GMD) growth assay and fluorescence-activated cell sorting,” J Exp Marine Biol. 329: 196-205 (2006). |
Akselband, “Rapid mycobacteria drug susceptibility testing using gel microdrop (GMD) growth assay and flow cytometry,” J Microbiol Methods. 62: 181-197 (2005). |
Ali-Cherif et al., “Programmable Magnetic Tweezers and Droplet Microfluidic Device for High-Throughput Nanoliter Multi-Step Assays,” Angew Chem Int Ed. 51: 10765-10769 (2012). |
Altemose et al., “Genomic Characterization of Large Heterochromatic Gaps in the Human Genome Assembly,” PLOS Computational PLoS Comput Biol. 10(5) (2014) (14 pages). |
Amini et al. “Haplotype-resolved whole-genome sequencing by contiguity-preserving transposition and combinatorial indexing” Nat Genet. 46(12):1343-1349 (2014). |
Anna et al., “Formation of dispersions using ‘flow focusing’ in microchannels,” Applied Physics Letters. 82(3): 364-366 (2003). |
Anonymous, “Oligo(dT)25 cellulose beads” NEB (2012) Retrieved from the Internet:https://www.neb.com/˜/media/Catalog/All-Products/286CA51268E24DE1B06F1CB288698B54/Datacards%20or%Manuals/S1408Datasheet-Lot0011205.pdf. |
Anonymous, “Oligotex Handbook” Qiagen (2012) XP055314680, Retrieved from the Internet: URL:http://www.qiagen.com/de/resources/download.apsx?id=f9fald98-d54d-47e7-a20b-8b0cb8975009&lang=en. |
Anonymous: “TCEP=HCI” Thermo Scientific, Dec. 31, 2013 (Dec. 31, 2013), XP055508461, Retrieved from the Internet: URL:https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0011306_TCEP_HCI_UG.pdf. |
Anonymous: “Viscosity-Basic concepts” (2004) XP055314117. Retrieved from the Internet: URL:http://lhtc.epfl.ch/webdav/site/lhtc/shared/import/migration/2_VISCOSITY.pdf. |
Ason et al. “DNA sequence bias during Tn5 transposition. Journal of molecular biology” J Mol Biol. 335(5):12-13-25 (2004). |
Attia et al., “Micro-injection moulding of polymer microfluidic devices,” Microfluidics and Nanofluidics. 7(1):1-28 (2009). |
Balikova et al. “Autosomal-dominant microtia linked to five tandem copies of a copy-number-variable region at chromosome 4p16,” Am J Hum Genet. 82(1):181-7 (2008). |
Bardin et al., “High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy,” Lab Chip. 11: 3990-3998 (2011). |
Baret et al., “Kinetic aspects of emulsion stabilization by surfactants: a microfluidic analysis,” Langmuir. 25:6088-6093 (2009). |
Baret et al., “Fluorescence-activated droplet sorting (FADS): efficient microfluidic cell sorting based on enzymatic activity,” Lab Chip. 9(13):1850-8 (2009). |
BD. BD Rhapsody™ Single-Cell Analysis System: Analyze hundreds of genes across tens of thousands of single cells in parallel. BD, Becton, Dickinson and Company. BDGM1012 Rev. 1. 2017. 8 pages. |
Becker et al., “Polymer Microfabrication Technologies for Microfluidic,” Anal Bioanal Chem. 390(1): 89-111 (2008). |
Belder, “Microfluidics with Droplets,” Angew Chem Int Ed. 44: 3521-3522 (2005). |
Bentzen et al., “Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes,” Nat Biotechnol. 34(10):1037-1045 (2016). |
Berkum et al. “Hi-C: a method to study the three-dimensional architecture of genomes,” J Vis Exp. (39):1869 (2010). |
Biles et al., “Low-fidelity Pyrococcus furiosis DNA polymerase mutants useful in error-prone PCR,” Nucleic Acids Res. 32(22):e176 (2004). |
Bilotkach et al., “Fabrication of PDMS Membranes with Aqueous Molds for Microfluidic Systems,” 12th Int'l Conference Miniaturized Sys for Chemistry and Life Scis (2008). |
Bjornsson et al., “Intra-individual change over time in DNA methylation with familial clustering,” JAMA. 299(24):2877-83 (2008). |
Bodi et al., “Comparison of Commercially Available Target Enrichment Methods for Next-Generation Sequencing,” J Biomol Tech. 24(2): 73-86 (2013). |
Boone et al., “Plastic advances microfluidic devices. The devices debuted in silicon and glass, but plastic fabrication may make them hugely successful in biotechnology application,” Analytical Chemistry. 78A-86A (2002). |
Boulanger et al., “Massively parallel haplotyping on microscopic beads for the high- throughput phase analysis of single molecules,” PLoS One.7(4):1-10 (2012). |
Boyle et al., “High-resolution genome-wide in vivo footprinting of diverse transcription factors in human cells,” Genome Res. 21(3):456-64 (2011). |
Braeckmans et al., “Scanning the Code,” Modern Drug Discovery. 28-32 (2003). |
Bransky et al., “A microfluidic droplet generator based on a piezoelectric actuator,” Lab Chip. 9(4):516-20 (2009). |
Brenner et al., “In vitro cloning of complex mixtures of DNA on microbeads: physical separation of differentially expressed cDNAs,” Proc Natl Acad Sci U S A. 97(4):1665-70 (2000). |
Brenner, et al., “Injection Molding of Microfluidic Chips by Epoxy-Based Master Tools” (Oct. 9, 2005). |
Briggs, et al. “Tumor-infiltrating immune repertoires captures by single-cell barcoding in emulsion” with Supplementary material. bioRxiv 134841; doi: https://doi.org/10.1101/134841. Posted May 5, 2017. |
Brody et al., “Biotechnology at Low Reynolds Numbers,” Biophys J. 71:3430-3441 (1996). |
Brouzes et al., “Droplet microfluidic technology for single-cell high-throughput screening,” Proc Natl Acad Sci U S A. 106(34):14195-200 (2009). |
Brown, K., Targeted Sequencing Using Droplet-Based Microfluidics, RainDance Technologies, 2009, 1-18. |
Browning et al., “Haplotype phasing: existing methods and new developments,” Nat Rev Genet. 12(10):703-14 (2011). |
Buchman et al., “Selective RNA amplification: a novel method using dUMP-containing primers and uracil DNA glycosylase,” PCR Methods Appl. 3(1):28-31 (1993). |
Buenrostro et al., “Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position,” Nat Methods. 10(12):1213-8 (2013). |
Buenrostro et al., “ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide,” Curr Protoc Mol Biol. 109: 21.29.1-21.29.9. (2015). |
Buenrostro et al., “Single-cell chromatin accessibility reveals principles of regulatory variation,” Nature. 523(7561):486-90 (2015). |
Burns et al., “An Integrated Nanoliter DNA Analysis Device,” Science. 282(5388):484-7 (1998). |
Burns et al., “Microfabricated structures for integrated DNA analysis,” Proc Natl Acad Sci U S A. 93(11):5556-5561 (1996). |
Burns et al., “The intensification of rapid reactions in multiphase systems using slug flow in capillaries,” Lab Chip. 1(1): 10-5 (2001). |
Cappuzzo et al., “Increased HER2 gene copy No. is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients,” J Clin Oncol. 23(22):5007-18 (2005). |
Carroll, “The selection of high-producing cell lines using flow cytometry and cell sorting,” Exp Op Biol. Therp. 4(11): 1821-1829 (2004). |
Caruccio et al. “Preparation of Next-Generation Sequencing Libraries Using Nextera Technology: Simultaneous DNA Fragmentation and Adaptor Tagging by In Vitro Transposition,” Methods Mol Biol. 733:241-55 (2011). |
Caruccio, et al., “Nextera Technology for NGS DNA Library Preparation: Simultaneous Fragmentation and Tagging by In Vitro Transposition,” Nextera Technology. 16-3: 1-3 (2009). |
Casbon et al., “Reflex: intramolecular barcoding of long-range PCR products for sequencing multiple pooled DNAs,” Nucleic Acids Res. 41(10) 1-6 (2013). |
Chan et al., “High-Temperature Microfluidic Synthesis of CdSe Nanocrystals in Nanoliter Droplets,” J Am Soc. 127: 13854-13861 (2005). |
Chang et al., “Droplet-based microfluidic platform for heterogeneous enzymatic assays,” Lab Chip. 13: 1817-1822 (2013). |
Chaudhary, “A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins,” Proc Natl Acad Sci USA. 87: 1066-1070 (1990). |
Chechetkin et al., “Sequencing by hybridization with the generic 6-mer oligonucleotide microarray: an advanced scheme for data processing,” J Biomol Struct Dyn. 8(1):83-101 (2000). |
Chen et al., “Chemical transfection of cells in picoliter aqueous droplets in fluorocarbon oil,” Anal Chem. 83(22): 8816-20 (2011). |
Chien et al., “Multiport flow-control system for lab-on-a-chip microfluidic devices,” Fresenius J Anal Chem. 371:106-111 (2001). |
Choi et al., “Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer,” Cancer Res. 68(13):4971-6 (2008). |
Chokkalingam et al., “Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics,” Lab Chip. 13(24):4740-4 (2013). |
Chou et al., “Disposable Microdevices for DNA Analysis and Cell Sorting,” Proc Solid-State Sensor and Actuator Workshop, Hilton Head, SC, Jun. 8-11, 1998. 11-14. |
Christian et al., “Targeting DNA double-strand breaks with TAL effector nucleases,” Genetics. 186 (2): 757-61 (2010). |
Christiansen et al., “The Covalent Eukaryotic Topoisomerase I-DNA Intermediate Catalyzes pH-dependent Hydrolysis and Alcoholysis,” J Biol Chem. 269(15):11367-11373 (1994). |
Christopher et al., “Microfluidic methods for generating continuous droplet streams,” J Phys D: Appl Phys. 40: R319-R336 (2007). |
Chu et al., “Controllable monodisperse multiple emulsions,” Angew Chem Int Ed Engl. 46(47): 8970-4 (2007). |
Chung et al., “Structural and molecular interrogation of intact biological systems,” Nature. 497(7449):332-7 (2013). |
Clark et al., “Single-cell epigenomics: powerful new methods for understanding gene regulation and cell identity,” Genome Biol. 17:72 (2016). |
Clausell-Tormos et al., “Droplet-based microfluidic platforms for the encapsulation and screening of mammalian cells and multicellular organisms,” Chem Biol. 15:427-437 (2008). |
Co-pending U.S. Appl. No. 15/440,772, filed Feb. 23, 2017. |
Co-pending U.S. Appl. No. 15/449,741, filed Mar. 3, 2017. |
Co-pending U.S. Appl. No. 16/033,065, filed Jul. 11, 2018. |
Co-pending U.S. Appl. No. 16/044,374, filed Jul. 24, 2018. |
Co-pending U.S. Appl. No. 16/107,685, filed Aug. 21, 2018. |
Co-pending U.S. Appl. No. 16/170,980, filed Oct. 25, 2018. |
Co-pending U.S. Appl. No. 16/180,378, filed Nov. 5, 2018. |
Co-pending U.S, Appl. No. 16/274,134, filed Feb. 12, 2019. |
Co-pending U.S. Appl. No. 16/419,820, filed May 22, 2019. |
Cong et al., “Multiplex genome engineering using CRISPR/Cas systems,” Science. 339 (6121) 819-23 (2013). |
Cook et al., “Copy-number variations associated with neuropsychiatric conditions,” Nature. 455(7215):919-23 (2008). |
Coufal et al., “L1 retrotransposition in human neural progenitor cells,” Nature. 460(7259):1127-31 (2009). |
Curcio, Mario, Thesis: “Improved Techniques for High-Throughput Molecular Diagnostics,” Doctor in Philosophy of Chemistry, Royal Institute of Technology, 2002 (131 pages). |
Cusanovich et al., “Supplementary materials for Multiplex single-cell profiling of chromatin accessibility by combinatorial cellular indexing,” Science. 348(6237):910-4 (2015). |
Cusanovich et al., “Multiplex single-cell profiling of chromatin accessibility by combinatorial cellular indexing,” Science. (6237): 910-4 (2015). |
Damean et al., “Simultaneous measurement of reactions in microdroplets filled by concentration gradients,” Lab Chip. 9(12): 1707-13 (2009). |
Dangla et al., “Droplet microfluidics driven by gradients of confinement,” Proc Natl Acad Sci U S A. 110(3): 853-858 (2013). |
De Bruin et al., “UBS Investment Research. Q-Series®: DNA Sequencing,” UBS Securities LLC (2007) (15 pages). |
Dekker et al., “Capturing chromosome conformation,” Science. 295(5558):1306-11 (2002). |
Demirci et al., “Single cell epitaxy by acoustic picolitre droplets,” Lab Chip. 7(9): 1139-45 (2007). |
Dendukuri et al., “Controlled synthesis of nonspherical microparticles Using Microfluidics,” Langmuir. 21: 2113-2116 (2005). |
Depristo et al., “A framework for variation discovery and genotyping using next-generation DNA sequencing data,” Nature Genet. 43(5):491-8 (2011). |
Dey et al., “Integrated genome and transcriptome sequencing of the same cell,” available in PMC Dec. 18, 2017, published in final edited form as: Nature Biotechnology. 33(3): 285-289 (2015). |
Dixit et al., “Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens,” Cell. 167(7):1853-1866.e17 (2016). |
Doerr, “The smallest bioreactor,” Nature Methods. 2(5): 326 (2005). |
Doshi et al., “Red blood cell-mimicking synthetic biomaterial particles,” Proc Natl Acad Sci U S A. 106(51):21495-21499 (2009). |
Dowding et al., “Oil core/polymer shell microcapsules by internal phase separation from emulsion droplets. II: controlling the release profile of active molecules,” Langmuir. 21(12): 5278-84 (2005). |
Draper et al., “Compartmentalization of electrophoretically separated analytes in a multiphase microfluidic platform,” Anal Chem. 84(13): 5801-8 (2012). |
Dressler et al., “Droplet-based microfluidics enabling impact on drug discovery,” J Biomol Screen. 19(4): 483-96 (2014). |
Dressman et al. Supplementary Information pp. 1-2 of article published 2003, PNAS 100(15:8817-22). |
Dressman et al., “Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations,” Proc Natl Acad Sci U S A.100(15):8817-22 (2003). |
Drmanac et al., “Sequencing by hybridization (SBH): advantages, achievements, and opportunities,” Adv Biochem Eng Biotechnol. 77: 75-101 (2002). |
“Droplet Based Sequencing,” slides dated Mar. 12, 2008. |
Duffy et al., “Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane),” Anal Chem. 70(23):4974-84 (1998). |
Eastburn et al., “Ultrahigh-throughput mammalian single-cell reverse-transcriptase polymerase chain reaction in microfluidic droplets,” Anal Chem. 85(16): 8016-21 (2013). |
Engl et al., “Controlled production of emulsions and particles by milli- and microfluidic techniques,” Current Opinion in Colloid and Interface Science. 13: 206-216 (2007). |
Epicentre .. “EZ-Tn5TM Custom Transposome Construction Kits”, http://www.epicentre.com. pp. 1-17, 2012. |
Erbacher et al., “Towards Integrated Continuous-Flow Chemical Reactors,” Mikrochimica Acta. 131: 19-24 (1999). |
Esser-Kahn et al., “Triggered release from polymer capsules,” Macromolecules. 44: 5539-5553 (2011). |
Fabi, et al. Correlation of efficacy between EGFR gene copy number and lapatinib/capecitabine therapy in HER2-positive metastatic breast cancer. J. Clin. Oncol. 2010; 28:15S. 2010 ASCO Meeting abstract Jun. 14, 2010:1059. |
Fan et al., “Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood,” Proc Natl Acad Sci U S A. 105(42):16266-71 (2008). |
Fan et al., “Whole-genome molecular haplotyping of single cells,” Nat Biotechnol. 29(1):51-7 (2011). |
Fang et al., “Fluoride-cleavable biotinylation phosphoramidite for 5′-end-labeling and affinity purification of synthetic oligonucleotides,” Nucleic Acids Res. 31(2):708-15 (2003). |
Ferraro et al., “Microfluidic platform combining droplets and magnetic tweezers: application to HER2 expression in cancer diagnosis,” Scientific Reports. 6:25540 (2016). |
Flisher et al., “A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries,” Genome Biol. 12(1):R1 (2011). |
Frampton et al., “Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing” Nat Biotechnol. 31(11):1023-1031 (2013). |
Fredrickson et al., “Macro-to-micro interfaces for microfluidic devices,” Lab Chip. 4(6): 526-33 (2004). |
Freiberg et al., “Polymer microspheres for controlled drug release,” Int J Pharm. 282(1-2): 1-18 (2004). |
Fu et al., “A Microfabricated Fluorescence-Activated Cell Sorter,” Nature Biotechnology. 17: 1109-1111 (1999). |
Fulton et al., “Advanced multiplexed analysis with the FlowMetrix system,” Clin Chem. 43(9): 1749-56 (1997). |
Gangadharan et al., “DNA transposon Hermes insert into DNA in nucleosome-free regions in vivo,” Proc Natl Acad Sci U S A. 107(51):21966-72 (2010). |
Gao et al., “Toehold of dsDNA Exchange Affects the Hydrogel Swelling Kinetic of a Polymer-dsDNA Hybrid Hydrogel,” Royal Soc Chem. 7:1741-1746 (2010). |
Garstecki et al., “Mechanism for Flow-Rate Controlled Breakup in Confined Geometries: A Route to Monodisperse Emulsions,” PRL. 94: 164501 (2005). |
Garstecki et al., “Formation of monodisperse bubbles in a microfluidic flow-focusing device,” Applied Physics Letters. 85(13): 2649-2651 (2004). |
Gartner et al., “The Microfluidic Toolbox—examples for fluidic interfaces and standardization concepts,” Proc SPIE 4982, Microfluidics, BioMEMS, and Medical Microsystems. (2003). |
Gericke et al., “Functional cellulose beads: preparation, characterization, and applications,” Chem Rev. 113(7) 4812-4836 (2013). |
Ghadessy et al., “Directed evolution of polymerase function by compartmentalized self-replication,” Proc Natl Acad Sci USA. 98: 4552-4557 (2001). |
Gonzalez et al., “The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility,” Science. 307(5714): 1434-40 (2005). |
Granieri, Lucia, Thesis: “Droplet-based microfluidics and engineering of tissue plasminogen activator for biomedical applications,” Doctor of Philosophy in Chemistry, L'Universite de Strasbourg, 2009 (131 pages). |
Grasland-Mongrain et al., “Droplet coalescence in microfluidic devices,” <http://www.eleves.ens.fr/home/grasland/rapports/stage4.pdf>, dated Jan.-Jul. 2003 (31 pages). |
Green et al., “Insertion site preference of Mu, Tn5, and Tn7 transposons,” Mob DNA 3(1):3 (2012). |
Greenleaf, “Assaying the epigenome in limited Nos. of cells,” Methods. 72:51-6 (2015). |
Guo et al., “Droplet microfluidics for high-throughput biological assays,” Lab Chip. 12(12):2146-55 (2012). |
Gyarmati et al., “Reversible disulphide formation in polymer networks: a versatile functional group from synthesis to applications,” European Polymer Journal. 49:1268-1286 (2013). |
Hamilton, “microRNA in erythrocytes,” Biochem Soc Trans. 38 (Pt 1): 229-231.(2010). |
Han et al., “Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next- Generation Sequencing,” PLOS One. 8(5):e64271 (2013). |
Han et al., “CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation” Science Advances. 1(7): E1500454 (2015) (8 pages). |
Haring et al., “Chromatin immunoprecipitation: optimization, quantitative analysis and data normalization., ”Plant Methods. 3:11 (2007). |
Hashimshony et al., “CEL-Seq: Single-Cell RNA-Seq by Multiplexed Linear Amplification,” Cell Rep. 2(3):666-73 (2012). |
He, “Selective Encapsulation of Single Cells and Subcellular Organelles into Picoliter- and Femtoliter-Volume Droplets,” Anal Chem. 77: 1539-1544 (2005). |
He et al., “Genotyping-by-sequencing (GBS), an ultimate marker-assisted selections (MAS) tool to accelerate plant breeding,” Frontiers Plant Sci. 5:1-8 (2014). |
Hettiarachchi et al., “Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapy,” Biotechnol Prog. 25(4): 938-45 (2009). |
Hiatt et al., “Parallel, tag-directed assembly of locally derived short sequence reads,” Nat Methods. 7(2):119-22 (2010). |
Hirsch et al. “Easily reversible desthiobiotin binding to streptavidin, avidin, and other biotin-binding proteins: uses for protein labeling, detection, and isolation.” Anal Biochem. 308(2):343-357 (2002). |
Hjerten et al., “General methods to render macroporous stationary phases nonporous and deformable, exemplified with agarose and silica beads and their use in high-performance ion-exchange and hydrophobic-interaction chromatography of proteins,” Chromatographia. 31.1-2: 85-94 (1991). |
Holmberg et al., “The biotin-streptavidin interaction can be reversibly broken using water at elevated temperatures,” Electrophoresis. 26(3):501-10 (2005). |
Holtze et al., “Biocompatible surfactants for water-in-fluorocarbon emulsions,” Lab Chip. 8(10): 1632-9 (2008). |
Hosokawa et al., “Massively parallel whole genome amplification for single-cell sequencing using droplet microfluidics,” Scientific Reports. 7: No. 5199 (2017). |
Hosono et al., “Unbiased whole-genome amplification directly from clinical samples, ” Genome Res. 13(5):954-64 (2003). |
Hu et al., “Shape Controllable Microgel Particles Prepared by Microfluidic Combining External Crosslinking,” Biomicrofluidics. 6(2):26502-265029 (2012). |
Huebner, “Quantitative detection of protein expression in single cells using droplet microfluidics,” Chem Commun. 1218-1220 (2007). |
Hug et al., “Measurement of the number of molecules of a single mRNA species in a complex mRNA preparation,” J Theor Biol. 221(4): 615-24 (2003). |
Hung et al., “PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches,” Lab chip. 10: 1820-1825 (2010). |
Hung et al., “Alternating droplet generation and controlled dynamic droplet fusion in microfluidic device for Cds nanoparticle synthesis,” Lab Chip. 6(2): 174-8 (2006). |
Illumina Nextera Enrichment Sample Preparation Guide. Feb. 2013. |
Illumina TruSeq Custom Enrichment Kit Data Sheet. (c) 2014. |
Imburgio et al., “Studies of promoter recognition and start site selection by T7 RNA polymerase using a comprehensive collection of promoter variants,” Biochemistry. 39(34):10419-30 (2000). |
Invitrogen Dynal, Product Sheet for “Dynabeads@ M-280 Streptavidin,” (2006) (2 pages). |
Ioannidis, N. Manufacturing of agarose-based chromatographic adsorbents with controlled pore and particle sizes. A thesis submitted to The University of Birmingham for the degree of Doctor of Philosophy. 2009. |
Ivanova et al., “Droplet Formation in a Thin Layer of a Two-Component Solution under the Thermal Action of Laser Radiation,” Colloid Journal. 69(6): 735-740 (2007). |
Jeffries et al., “Controlled Shrinkage and Re-expansion of a Single Aqueous Droplet inside an Optical Vortex Trap,” J Phys Chem B. 111(11): 2806-2812 (2007). |
Jeffries et al., “Dynamic modulation of chemical concentration in an aqueous droplet,” Angew Chem Int Ed Engl. 46(8): 1326-1328 (2007). |
Jena et al., “Cyclic olefin copolymer based microfluidic devices for biochip applications: Ultraviolet surface grafting using 2-methacryloyloxyethyl phosphorylcholine,” Biomicrofluidics. 6(1): 12822-1282212 (2012). |
Joanicot et al., “Droplet Control For Microfluidics,” Science. 309:887-888 (2005). |
Johnson, “Rapid microfluidic mixing,” Analytical Chemistry. 74(1): 45-51 (2002). |
Joneja et al., “Linear nicking endonuclease-mediated strand-displacement DNA amplification,” Anal Biochem. 414(1):58-69 (2011). |
JPK “Determining the elastic modulus of biological samples using atomic force microscopy” (https://www.jpk.com/app-technotes-img/AFM/pdf/jpk-app-elastic-modulus.14-1.pdf) 2009, pp. 1-9 (Year: 2009). |
Jung et al., “Micro machining of injection mold inserts for fluidic channel of polymeric biochips,” Sensors. 7(8): 1643-1654 (2007). |
Kamperman et al., “Centering Single Cells in Microgels via Delayed Crosslinking Supports Long-Term 3D Culture by Preventing Cell Escape,” Small. 13(22) (2017). |
Kaper et al., “Supporting Information for Whole-genome haplotyping by dilution, amplification, and sequencing,” Proc Natl Acad Sci U S A. 110(14):5552-7 (2013). |
Kaper et al., “Whole-genome haplotyping by dilution, amplification, and sequencing,” Proc Natl Acad Sci U S A. 110(14):5552-7 (2013). |
Karmakar et al., “Organocatalytic removal of formaldehyde adducts from RNA and DNA bases,” Nat Chem. 7(9):752-8 (2015). |
Katsura et al., “Indirect micromanipulation of single molecules in water-in-oil emulsion,” Electrophoresis. 22(2): 289-93 (2001). |
Kawari et al., “Mass-Production System of Nearly Monodisperse Diameter Gel Particles Using Droplets Formation in a Microchannel,” Micro Total Analysis Systems. 1:368-370 (2002). |
Kebschull et al., “High-Throughput Mapping of Single-Neuron Projections by Sequencing of Barcoded RNA,” Neuron. 91(5):975-87 (2016). |
Kenis et al., “Microfabrication Inside Capillaries Using Multiphase Laminar Flow Patterning,” Science. 285: 83-85 (1999). |
Khomiakova et al., “Analysis of perfect and mismatched DNA duplexes by a generic hexanucleotide microchip,” Mol Biol (Mosk). 37(4): 726-41 (2003) (Abstract only). |
Kim et al., “Albumin loaded microsphere of amphiphilic poly( ethylene glycol)/poly(a-ester) multiblock copolymer,” Eu J Pharm Sci. 23: 245-51 (2004). |
Kim et al., “Fabrication of monodisperse gel shells and functional microgels in microfluidic devices,” Angew Chem Int Ed Engl. 46(11): 1819-22 (2007). |
Kim et al., “Rapid prototyping of microfluidic systems using a PDMS/polymer tape composite,” Lab Chip. 9(9): 1290-3 (2009). |
Kirkness et al., “Sequencing of isolated sperm cells for direct haplotyping of a human genome,” Genome Res. 23:826-83 (2013). |
Kitzman et al., “Haplotype-resolved genome sequencing of a Gujarati Indian individual.” Nat Biotechnol. 29:59-63 (2011). |
Kitzman et al., “Noninvasive whole-genome sequencing of a human fetus,” Sci Transl Med. 4(137):137ra76 (2016). |
Kivioja et al., “Counting absolute Nos. of molecules using unique molecular identifiers,” Nat Methods. 9(1):72-4 (2011). |
Klein et al., “Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells,” Cell. 161(5): 1187-201 (2015). |
Knapp et al., “Generating barcoded libraries for multiplex high-throughput sequencing,” Methods Mol Biol. 840:155-70 (2012). |
Knight et al., “Subtle chromosomal rearrangements in children with unexplained mental retardation,” Lancet. 354(9191):1676-81 (1999). |
Kobayashi et al., “Straight-Through Microchannel Devices For Generating Monodisperse Emulsion Droplets Several Microns In Size,” Microfluid Nanofluid. 4: 167-177 (2008). |
Kobayashi et al., “Effect of slot aspect ratio on droplet formation from silicon straight-through microchannels,” J Colloid Interface Sci. 279(1): 277-80 (2004). |
Kohler et al., “Nanoliter Segment Formation in Micro Fluid Devices For Chemical and Biological Micro Serial Flow Processes in Dependence on Flow Rate and Viscosity,” Sensors and Actuators A. 119: 19-27 (2005). |
Kolodeziejczyk et al., “The technology and biology of single-cell RNA sequencing,” Molecular Cell. 58(4): 610-20 (2015). |
Korlach et al., “Methods in Enzymology, Real-Time DNA Sequencing from Single Polymerase Molecules,” 472:431-455 (2010). |
Koster et al., “Drop-based microfluidic devices for encapsulation of single cells,” Lab Chip. 8(7): 1110-1115 (2008). |
Kozarewa et al., “96-plex molecular barcoding for the Illumina Genome Analyzer,” Methods Mol Biol. 733:279-98 (2011). |
Kozarewa et al., “Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of GC-biased genomes,” Nat Methods. 6: 291-5 (2009). |
Kutyavin, et al., “Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents,” Biochemistry. 35(34):11170-6 (1996). |
Kwok et al., “Single-molecule analysis for molecular haplotyping,” Hum Mutat. 23:442-6 (2004). |
Lagally et al., “Single-Molecular DNA Amplification and Analysis in an Integrated Microfluidic Device,” Anal Chem. 73(3): 565-70 (2001). |
Lagus et al., “A review of the theory, methods and recent applications of high-throughput single-cell droplet microfluidics,” J Phys D Appl Phys. 46:114005 (2013) (21 pages). |
Lai et al., “Characterization and Use of Laser-Based Lysis for Cell Analysis on-Chip,” Journal of the Royal Society. 5(2): S113-S121(2008). |
Laird et al., “Hairpin-bisulfite PCR: Assessing epigenetic methylation patterns on complementary strands of individual DNA molecules,” PNAS. 101, 204-209 (2004). |
Lake et al., “Integrative Single-Cell Analysis By Transcriptional And Epigenetic States in Human Adult Brain,” Apr. 19, 2017. doi: https://doi.org/10.1101/128520. |
Lan et al. “Single-cell genome sequencing at ultra-high-throughput with microfluidic droplet barcoding” Nat Biotechnol. 35(7):640-646(2017). |
Lander et al., “Initial sequencing and analysis of the human genome,” Nature. 409: 860-921 (2001). |
Lasken et al., “Archaebacterial DNA Polymerases Tightly Bind Uracil-containing Dna,” J Biol Chem. 271(30):17692-17696 (1996). |
Laulicht et al., “Evaluation of continuous flow nanosphere formation by controlled microfluidic transport,” Langmuir. 24(17): 9717-26 (2008). |
Lebedev et al,. “Hot Start PCR with heat-activatable primers: a novel approach for improved PCR performance,” NAR. 36(20):E131-1 (2008). |
Lee et al., “Alginate: Properties and biomedical applications,” Prog Polym Sci. 37(1):106-126 (2012). |
Lee et al., “A tunable microflow focusing device utilizing controllable moving walls and its applications for formation of micro-droplets in liquids,” J Micromech Microeng. 17: 1121-1129 (2007). |
Lee et al., “Double emulsion-templated nanoparticle colloidosomes with selective permeability,” Adv Mater. 20: 3498-503 (2008). |
Lee et al., “ACT-PRESTO: Rapid and consistent tissue clearing and labeling method for 3-dimensional (3D) imaging,” Sci Rep. 6:18631 (2016). |
Lee et al., “Highly multiplexed subcellular RNA sequencing in situ,” Science. 343(6177): 1360-3 (2014). |
Lee et al., “Microfluidic air-liquid cavity acoustic transducers for on-chip integration of sample preparation and sample detection,” JALA. 15(6): 449-454 (2010). |
Lee et al., “Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues,” Nature Protocols. 10(3):442-458 (2015). |
Lennon et al., “A scalable, fully automated process for construction of sequence-ready barcoded libraries for 454,” Genome Biol. 11(2):R15 (2010). |
Li et al., “A single-cell-based platform for copy No. variation profiling through digital counting of amplified genomic DNA fragments,” ACS Appl Mater Interfaces. doi: 10.1021/acsami.7b03146 (2017). |
Li et al., “Step-emulsification in a microfluidic device,” Lab Chip. 15(4): 1023-31 (2015). |
Li et al., “PEGylated PLGA Nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats,” Journal of Controlled Release. 71: 203-211 (2001). |
Lienemann et al., “Single cell-laden protease-sensitive microniches for long-term culture in 3,”. Lab Chip. 17(4):727-737(2017). |
Linch et al., “Bone marrow processing and cryopreservation,” Journal of Clinical Pathology. 35(2): 186-190 (1982). |
Liu et al., “Droplet-based synthetic method using microflow focusing and droplet fusion,” Microfluid Nanofluid. 3: 239-24 (2007). |
Liu et al., “Dynamics of coalescence of plugs with a hydrophilic wetting layer induced by flow in a microfluidic chemistrode,” Langmuir. 25(5): 2854-9 (2009). |
Liu et al., “Droplet formation in a T-shaped microfluidic junction,” Journal of Applied Physics. 106: 034906 (2009). |
Liu et al., “Preparation of uniform-sized PLA microcapsules by combining Shirasu porous glass membrane emulsification technique and multiple emulsion-solvent evaporation method,” J Control Release. 103(1): 31-43 (2005). |
Liu et al., “Smart thermo-triggered squirting capsules for Nanoparticle delivery,” Soft Matter. 6(16): 3759-3763 (2010). |
Lo et al., “On the design of clone-based haplotyping,” Genome Biol. 14(9):R100 (2013). |
Lorenceau et al., “Generation of Polymerosomes from Double-Emulsions,” Langmuir. 21: 9183-9186 (2005). |
Loscertales et al., “Micro/Nano Encapsulation via Electrified Coaxial Liquid Jets,” Science. 295: 1695-1698 (2002). |
Love, “A microengraving method for rapid selection of single cells producing antigen-specific antibodies,” Nature Biotech. 24(6): 703 (2006). |
Lowe, Adam James, Thesis: “Norbornenes and [n]polynorbornanes as molecular scaffolds for anion recognition,” Doctor of Philosophy, Deakin University, 2010 (361 pages). |
Lundin et al., “Hierarchical molecular tagging to resolve long continuous sequences by massively parallel sequencing,” Sci Rep. 3:1186 (2003). |
Lupski et al., “Genomic rearrangements and sporadic disease,” Nat Genet. 39(7 Suppl):S43-7 (2007). |
Maan et al., “Spontaneous droplet formation techniques for monodisperse emulsions preparation—Perspectives for food applications,” Journal of Food Engineering. 107(3-4): 334-346 (2011). |
Macaulay et al., “Single-Cell Multiomics: Multiple Measurements from Single Cells,” available in PMS Dec. 18, 2017, published in final edited form as: Trends in Genetics. 33(2): 155-168 (2017). |
Macaulay et al., “G&T-seq: parallel sequencing of single-cell genomes and transcriptomes,” Nature Methods. p. 1-7 (2005). |
Macosko et al., “Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets,” Cell. 161(5): 1202-14 (2015). |
Mair et al., “Injection molded microfluidic chips featuring integrated interconnects,” Lab Chip. 6(10): 1346-54 (2006). |
Makino et al., “Preparation of hydrogel microcapsules: Effects of preparation conditions upon membrane properties,” Colloids and Surfaces B: Biointerfaces. 12(2): 97-104 (1998). |
Malic et al., “Integration and detection of biochemical assays in digital microfluidic LOC devices,” Lab Chip. 10: 418-431 (2010). |
Malsch et al., “μPIV-Analysis of Taylor flow in micro channels,” Chemical Engineering Journal. 135S: S166-S172 (2008). |
Man, Piu Francis, Thesis: “Monolithic Structures for Integrated Microfluidic Analysis,” Doctor of Philosophy in Electrical Engineering, University of Michigan, 2001 (145 pages). |
Marcus, “Gene method offers diagnostic hope,” The Wall Street Journal, <https://www.wsj.com/articles/SB10001424052702303644004577520851224339844>, dated Jul. 11, 2012. |
Maricic et al., “Optimization of 454 sequencing library preparation from small amounts of DNA permits sequence determination of both DNA strands,” Biotechniques. 46(1):51-2, 54-7 (2009). |
Mason et al., “Shear Rupturing of Droplets in Complex Fluids,” Langmuir. 13(17):4600-4613 (1997). |
Matochko et al., “Uniform amplification of phage display libraries in monodisperse emulsions,” Methods. 58(1): 18-27 (2012). |
Mazutis et al., “Droplet-Based Microfluidic Systems for High-Throughput Single DNA Molecule Isothermal Amplification and Analysis,” Anal Chem. 81(12): 4813-4821 (2009). |
Mazutis et al., “Selective droplet coalescence using microfluidic systems,” Lab Chip. 12(10): 1800-6 (2012). |
Mazutis et al., “Preparation of monodisperse emulsions by hydrodynamic size fractionation,” Appl Phys Lett. 95: 204103 (2009). |
Mcginnis et al., “MULTI-seq: Scalable sample multiplexing for single-cell RNA sequencing using lipid-tagged indices,” bioRxiv 387241; doi: https://doi.org/10.1101/387241. |
Meier et al., “Plug-Based Microfluidics with Defined Surface Chemistry to Miniaturize and control aggregation of amyloidogenic peptides,” Angew Chem Ed Engl. 48(8): 1487-1489 (2009). |
Merriman et al., “Progress in ion torrent semiconductor chip based sequencing,” Electrophoresis. 33(23): 3397-417 (2012). |
Microfluidic ChipShop, Microfluidic Product Catalogue, dated Feb. 2005. |
Microfluidic ChipShop, Microfluidic product catalogue, dated Mar. 2005. |
Microfluidic ChipShop, Microfluidic product catalogue, dated Oct. 2009. |
Miller et al., “An improved zinc-finger nuclease architecture for highly specific genome editing,” Nat Biotechnol. 25:778-785 (2007). |
Miller-Stephenson Chemicals 157 FS Series catalog, www.miller-stephenon.com. |
MiRNA (http://www.exiqon.com/what-are-microRNAs) accessed Oct. 19, 2017. |
Mirzabekov, “DNA Sequencing by Hybridization—a Megasequencing Method and A Diagnostic Tool?” Trends in Biotechnology. 12(1): 27-32 (1994). |
Moore et al., “Behavior of capillary valves in centrifugal microfluidic devices prepared by three-dimensional printing,” Microfluidics and Nanofluidics. 10(4):877-888 (2011). |
Morgan et al., “Chapter 12: Human microbiome analysis,” PLoS Comput Biol. 8(12):e1002808 (2012). |
Morimoto et al., “Monodisperse semi-permeable microcapsules for continuous observation of cells,” Lab Chip 9(15):2217-2223 (2009). |
Morton, “Parameters of the human genome,” Proc Natl Acad Sci U S A. 88(17):7474-6 (1991). |
Mouritzen et al., “Single nucleotide polymorphism genotyping using locked nucleic acid (LNa),” Expert Rev Mol Diagn. 3(1): 27-38 (2003). |
Mozhanova, A.A. et al. “Local elastic properties of biological materials studied by SFM” (2003) XP055314108, Retrieved from the Internet: URL:http://www.ntmdt.com/data/media/files/publications/2003/08.08_a.a.mozhanova_n.i.n_english.pdf. |
Muotri et al., “L1 retrotransposition in neurons is modulated by MeCP2,” Nature. 468(7322):443-6 (2010). |
Myllykangas et al., “Targeted Sequencing Library Preparation By Genomic DNA Circularization,” BMC Biotechnology. 11(122), 1-12 (2011). |
Nagano et al., “Single-cell Hi-C reveals cell-to-cell variability in chromosome structure,” Nature. 502(7469):59-64 (2013). |
Nagashima et al., “Preparation of monodisperse poly (acrylamide-co-acrylic acid) hydrogel microspheres by a membrane emulsification technique and their size-dependent surface properties,” Colloids and Surfaces B: Biointerfaces. 11(1-2): 47-56 (1998). |
Narayanan et al., “Determination of agarose gel pore size: Absorbance measurements vis a vis other techniques,” Journal of Physics: Conference Series 28. 83-86 (2006). |
National Human Genome Research Institute (NHGRI), “The Human Genome Project Completion: Frequently Asked Questions,” retrieved from <https://www.genome.gov/11006943/human-genome-project-completion-frequently-asked-questions/> on May 10, 2018, last updated Oct. 30, 2010 (8 pages). |
Navin, “The first five years of single-cell cancer genomics and beyond,” Genome Res. 25(10):1499-507 (2015). |
Nguyen et al., “In situ hybridization to chromosomes stabilized in gel microdrops,” Cytometry. 21(2):111-9 (1995). |
Nisisako et al., “Novel microreactors for functional polymer beads,” Chem Eng J. 101(1-3):23-9 (2004). |
Nisisako et al., “Synthesis of Monodisperse Bicolored Janus Particles with Electrical Anisotropy Using a Microfluidic Co-Flow System,” Adv Mater. 18(9):1152-6 (2006). |
Nisisako et al., “Droplet formation in a microchannel network,” Lab Chip. 2(1):24-6 (2002). |
Nisisako et al., “Droplet Formation in a Microchannel on PMMA Plate,” Micro Total Analysis Systems 2001. J.M. Ramsey and A. van den Berg, 137-138 (2001). |
Nisisako et al., “Microfluidic large-scale integration on a chip for mass production of monodisperse droplets and particles,” Lab Chip. 8(2):287-293 (2008). |
Niu et al., “Droplet-based compartmentalization of chemically separated components in two-dimensional separations,” Chem Commun (Camb). (41):6159-61 (2009). |
Niu et al., “A hybrid microfluidic chip for digital electro-coalescence of droplets, ” Thirteenth International Conference on Miniaturized Systems for Chemistry and Life Sciences, Nov. 1-5, Jeju, Korea. pp. 94-96 (2009). |
Novak et al., “Single cell multiplex gene detection and sequencing using microfluidically-generated agarose emulsions,” available in PMC Jan. 10, 2012, published in final edited form as: Angew Chem Int Ed Engl. 50(2):390-5 (2011) (10 pages). |
Oberholzer et al., “Polymerase chain reaction in liposomes,” Chem Biol. 2(10):677-82 (1995). |
Ogawa et al., “Production and characterization of O/W emulsions containing cationic droplets stabilized by lecithin-chitosan membranes,” J Agric Food Chem. 51(9):2806-12 (2003). |
Okushima et al., “Controlled Production of Monodisperse Double Emulsions by Two-Step Droplet Breakup in Microfluidic Devices,” Langmuir. 20(23):9905-8 (2004). |
Oligotex Handbook. For purification of poly A+ RNA from total RNA and directly from cultured cells or tissues as well as purification of polyadenylated in vitro transcripts. Jun. 2012. |
Ong et al., “Experimental and computational analysis of droplet formation in a high-performance flow-focusing geometry,” Sensors and Actuators A: Physical. 138(1):203-12 (2007). |
Orakdogen et al., “Novel responsive poly(N,N-dimethylaminoethyl methacrylate) gel beads: preparation, mechanical properties and pH-dependent swelling behavior,” J Polym Res. 19:9914 (2012). |
Oyola et al., “Optimizing Illumina next-generation sequencing library preparation for extremely AT-biased genomes,” BMC Genomics. 13:1 (2012). |
Pantel et al., “Detection methods of circulating tumor cells,” J Thorac Dis. 4(5):446-7 (2012). |
Park et al., “ChIP-seq: advantages and challenges of a maturing technology,” Nature Reviews Genetics. 10: 669-680 (2009). |
Patel et al., “Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma,” Science. 344(6190):1396-401 (2014). |
Perez et al., “Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid Dna,” J Control Release. 75(1-2):211-24 (2001). |
Perrott, Jimmy, Thesis: “Optimization and Improvement of Emulsion PCR for the lon Torrent Next-Generation Sequencing Platform,” Bachelor of Science in Bioengineering, University of California, Santa Cruz, 2011 (25 pages). |
Perroud et al., “Isotropically etched radial micropore for cell concentration, immobilization, and picodroplet generation,” Lab Chip. 9(4):507-15 (2009). |
Peters et al., “Accurate whole-genome sequencing and haplotyping from 10 to 20 human cells,” Nature. 487(7406):190-5 (2012). |
Picot et al., “A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen” Am J Hematology. 90(4):339-345 (2015). |
Pinto et al., “Functional impact of global rare copy number variation in autism spectrum disorders,” Nature. 466(7304):368-72 (2015). |
Plunkett et al., “Chymotrypsin responsive hydrogel: application of a disulfide exchange protocol for the preparation of methacrylamide containing peptides,” Biomacromolecules. 6(2):632-7 (2005). |
Porteus et al., “Chimeric nucleases stimulate gene targeting in human cells,” Science. 300(5620):763 (2003). |
Pott et al., “Single-cell ATAC-seq: strength in numbers,” Genome Biol. 16(1):172 (2015). |
Preissl, et al. Single nucleus analysis of the chromatin landscape in mouse forebrain development. Posted Jul. 4, 2017. bioRxiv 159137; doi: https://doi.org/10.1101/159137. |
Qiagen, “Omniscript® Reverse Transcription Handbook,” Oct. 2010 (32 pages). |
Rakszewska, A. et al. “One drop at a time: toward droplet microfluidics as a versatile tool for single-cell analysis” NPG Asia Materials (2014) 6(10):e133 (12 pages). |
Ram et al., “Strategy for microbiome analysis using 16S rRNA gene sequence analysis on the Illumina sequencing platform,” Syst Biol Reprod Med. 57(3):162-70 (2011). |
Ramsey, “The burgeoning power of the shrinking laboratory” Nat Biotechnol. 17(11):1061-2 (1999). |
Ramskold et al., “Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells” Nat Biotechnol. 30(8):777-782 (2012). |
Ran et al., “Genome engineering using the CRISPR-Cas9 system,” available in PMC Mar. 30, 2014, published in final edited form as: Nat Protoc. 8(11):2281-2308 (2013) (49 pages). |
Reis et al., “CRISPR/Cas9 and Targeted Genome Editing: A New Era in Molecular Biology,” XP002766825: URL:https://ww.neb.com/tools-and-resources/feabture-articles/crispr- cas9-and-targeted-genome-editing-a-new-era-in-molecular-biology (2014). |
Reisner et al., “Single-molecule denaturation mapping of DNA in nanofluidic channels,” Proc Natl Acad Sci U S.A., 107: 13294-9,(2010). |
Repp et al., “Genotyping by Multiplex Polymerase Chain Reaction for Detection of Endemic Hepatitis B Virus Transmission” J Clinical Microbiology. 31:1095-1102 (1993). |
Richardson et al., “Novel inhibition of archaeal family-D DNA polymerase by uracil,” Nucleic Acids Res. 41(7):4207-18 (2013). |
Roche, “Using Multiplex Identifier (MID) Adaptors for the GS FLX Titanium Chemistry Basic MID Set Genome Sequencer FLX System,” Technical Bulletin 004-2009, <http://454.com/downloads/my454/documentation/technical-bulletins/TCB-09004 UsingMultiplexIdentifierAdaptorsForTheGSFLXTitaniumSeriesChemistry-BasicMIDSet.pdf>, dated Apr. 1, 2009 (7 pages). |
Roche, “Using Multiplex Identifier (MID) Adaptors for the GS FLX Titanium Chemistry Extended MID Set Genome Sequencer FLX System,” Technical Bulletin 005-2009, <http://454.com/downloads/my454/documentation/technical-bulletins/TCB-09005UsingMultiplexIdentifierAdaptorsForTheGSFLXTitaniumChemistry-ExtendedMIDSet.pdf>, dated Apr. 1, 2009 (7 pages). |
Rodrigue et al., “Whole genome amplification and de novo assembly of single bacterial cells,” PLoS One. 4(9):e6864 (2009). |
Rogozin et al., “A highly conserved family of inactivated archaeal B family DNA polymerases,” Biol Direct. 3:32 (2008). |
Ropers, “New perspectives for the elucidation of genetic disorders,” Am J Hum Genet. 81(2):199-207 (2007). |
Rotem et al., “High-Throughput Single-Cell Labeling (Hi-SCL) for RNA-Seq Using Drop-Based Microfluidics,” PLoS One. 10(5):e0116328 (2015). |
Rotem et al., “Single Cell Chip-Seq Using Drop-Based Microfluidics,” Frontiers of Single Cell Analysis, September 5-7, Stanford University. Abstract #50 (2013). |
Rotem et al., “Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state,” Nat Biotechnol. 33(11):1165-72 (2015). |
Ryan et al., “Rapid assay for mycobacterial growth and antibiotic susceptibility using gel microdrop and encapsulation,” J Clin Microbiol. 33(7):1720-6 (1995). |
Sahin et al., “Microfluidic EDGE emulsification: the importance of interface interactions on droplet formation and pressure stability,” Sci Rep. 6:26407 (2016). |
Sakaguchi et al., “Cautionary Note on the Use of dUMP-Containing PCR Primers with Pfu and VentR®,” BioTechniques. 21(3): 369-370 (1996). |
Sander et al., “Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA),” Nat Methods. 8(1):67-9 (2011). |
Savva et al., “The structural basis of specific base-excision repair by uracil-DNA glycosylase,” Nature. 373(6514):487-93 (1995). |
Schirinzi et al., “Combinatorial sequencing-by-hybridization: Analysis of the NF1 gene,” Genet Test. 10(1):8-17 (2006). |
Schmeider et al., “Fast identification and removal of sequence contamination from genomic and metagenomic datasets,” PLoS One. 6(3):e17288 (2011). |
Schmitt et al., “Bead-based multiplex genotyping of human papillomaviruses,” J Clin Microbiol. 44(2):504-12 (2006). |
Schubert et al., “Microemulsifying fluorinated oils with mixtures of fluorinated and hydrogenated surfactants,” Colloids and Surfaces A: Physicochemical and Engineering Aspects. 84(1):97-106 (1994). |
Schwartz et al., “Capturing native long-range contiguity by in situ library construction and optical sequencing,” Proc Natl Acad Sci U S A. 109(46):18749-54 (2012). |
Sebat et al., “Strong association of de novo copy number mutations with autism,” Science. 316(5823):445-9 (2007). |
Seiffert et al., “Microfluidic fabrication of smart microgels from macromolecular precursors,” Polymer. 51(25):5883-9 (2010). |
Seiffert et al., “Smart microgel capsules from macromolecular precursors,” J Am Chem Soc. 132(18):6606-9 (2010). |
Sessoms et al., “Droplet motion in microfluidic networks: Hydrodynamic interactions and pressure-drop measurements,” Phys Rev E Stat Nonlin Soft Matter Phys. 80(1 Pt 2):016317 (2009). |
Shah et al., “Fabrication of monodisperse thermosensitive microgels and gel capsules in microfluidic devices,” Soft Matter. 4(12):2303-9 (2008). |
Shahi et al., “Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding,” Sci Rep. 7:44447 (2017). |
Shaikh et al., “A modular microfluidic architecture for integrated biochemical analysis,” Proc Natl Acad Sci U S A. 102(28):9745-9750 (2005). |
Shimkus et al., “A chemically cleavable biotinylated nucleotide: usefulness in the recovery of protein-DNA complexes from avidin affinity columns,” Proc Natl Acad Sci U S A. 82(9):2593-7 (1985). |
Shlien et al., “Copy number variations and cancer,” Genome Med. 1(6):62 (2009). |
Shlien et al., “Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome,” Proc Natl Acad Sci U S A. 105(32):11264-9 (2008). |
Shuttleworth et al., “Recognition of the pro-mutagenic base uracil by family B DNA polymerases from archaea,” J Mol Biol. 337(3):621-34 (2004). |
“Streptavidin-agarose (S1638) product information sheet,” Sigma, <www.sigma-aldrich.com>. |
Simeonov et al., “Single nucleotide polymorphism genotyping using short, fluorescently labeled locked nucleic acid (LNA) probes and fluorescence polarization detection,” Nucleic Acids Res. 30(17):e91 (2002). |
Simon et al., “Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA,” Nat Protoc. 7(2):256-67 (2012). |
Skerra, “Phosphorothioate primers improve the amplification of DNA sequences by DNA polymerases with proofreading activity,” Nucleic Acids Res. 20(14):3551-4 (1992). |
Smith et al., “Highly-multiplexed barcode sequencing: an efficient method for parallel analysis of pooled samples,” Nucleic Acids Res. 38(13):e142 (2010). |
Song et al., “Reactions in droplets in microfluidic channels,” Angew Chem Int Ed Engl. 45(44):7336-56 (2006). |
Song et al., “DNase-seq: A High-Resolution Technique for Mapping Active Gene Regulatory Elements across the Genome from Mammalian Cells,” Cold Spring Harb Protoc. 2 (2010) (13 pages). |
Sorokin et al., “Discrimination between perfect and mismatched duplexes with oligonucleotide gel microchips: role of thermodynamic and kinetic effects during hybridization,” J Biomol Struct Dyn. 22(6):725-34 (2005). |
“Spormann Laboratory, Polymerase Chain Reaction (PCR),” Alfred Spormann Laboratory. 1-3 (2009). |
Srisa-Art et al., “High-throughput DNA droplet assays using picoliter reactor volumes,” Anal Chem. 79(17):6682-9 (2007). |
Stoeckius et al., “Large-scale simultaneous measurement of epitopes and transcriptomes in single cells,” available in PMC Jan. 31, 2018, published in final edited form as: Nat Methods. 14(9):865-868 (2017). |
Stoeckius et al., “Simultaneous epitope and transcriptome measurement in single cells,” Nat Methods. 14: 865-868 (2017) (Supplemental Materials). |
Su et al., “Microfluidics-Based Biochips: Technology Issues, Implementation Platforms, and Design—Automation Challenges,” IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems. 25(2):211-23 (2006). |
Sun et al., “Progress in research and application of liquid-phase chip technology,” Chin J Exp Surg. 22(5):639-40 (2005) (7 pages). |
Susaki et al., “Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis,” Cell. 157(3):726-39 (2014). |
Syed et al., “Next-generation sequencing library preparation: simultaneous fragmentation and tagging using in vitro transposition,” Nat Methods. 6: i-ii (2009). |
Tawfik et al., “Man-made cell-like compartments for molecular evolution,” Nat Biotechnol. 16(7):652-6 (1998). |
Tayyab et al., “Size exclusion chromatography and size exclusion HPLC of proteins,” Biochem Ed, Pergamon. 19(3):149-152 (1991). |
Tetradis-Meris et al., “Novel parallel integration of microfluidic device network for emulsion formation,” Ind Eng Chem Res. 48(19):8881-9 (2009). |
Tewhey et al., “Supplementary Materials,” Nature Biotechnology. 27(11): 1-22 (2009). |
Tewhey et al., “Microdroplet-based PCR amplification for large-scale targeted sequencing,” available in PMC May 1, 2010, published in final edited form as: Nat Biotechnol. 27(11):1025-31 (2009) (22 pages). |
Theberge et al., “Microdroplets in microfluidics: an evolving platform for discoveries in chemistry and biology,” Angew Chem Int Ed Engl. 49(34):5846-68 (2010). |
“Protocols, M-270 Streptavidin,” ThermoFisherScientific. (2007) (5 pages). |
Thorsen et al., “Dynamic pattern formation in a vesicle-generating microfluidic device,” Phys Rev Lett. 86(18):4163-4166 (2001). |
Tomer et al., “Advanced CLARITY for rapid and high-resolution imaging of intact tissues,” Nat Protoc. 9(7):1682-97 (2014). |
Tonelli et al., “Perfluoropolyether functional oligomers: unusual reactivity in organic chemistry” Journal of Fluorine Chemistry. 118(1-2):107-21 (2002). |
Tubeleviciute et al., “Compartmentalized self-replication (CSR) selection of Thermococcus litoralis Sh1B DNA polymerase for diminished uracil binding,” Protein Eng Des Sel. 23(8):589-97 (2010). |
Turner et al., “High-throughput haplotype determination over long distances by haplotype fusion PCR and ligation haplotyping,” Nat Protoc. 4(12):1771-83 (2009). |
Turner et al., “Assaying chromosomal inversions by single-molecule haplotyping,” Nat Methods. 3(6):439-45 (2006). |
Turner et al., “Methods for genomic partitioning,” Annu Rev Genomics Hum Genet. 10:263-84 (2009). |
Umbanhowar et al., “Monodisperse Emulsion Generation via Drop Break Off in a Coflowing Stream,” Langmuir. 16(2):347-51 (2000). |
Ushijima et al., “Detection and interpretation of altered methylation patterns in cancer cells,” Nat Rev Cancer. 5: 223-231 (2005). |
Van Dijke et al., “Effect of viscosities of dispersed and continuous phases in microchannel oil-in-water emulsification,” Microfluid Nanofluid. 9:77-85 (2010). |
Van Nieuwerburgh et al., “Illumina mate-paired DNA sequencing-library preparation using Cre-Lox recombination,” Nucleic Acids Res. 40(3): e24 (2012). |
Wagner et al., “Biocompatible fluorinated polyglycerols for droplet microfluidics as an alternative to PEG-based copolymer surfactants,” Lab Chip. 16(1):65-9 (2016). |
Wang et al., “Self-Formed Adaptor PCR: a Simple and Efficient Method for Chromosome Walking,” Appl Environ Microbiol. 73(15):5048-51 (2007). |
Wang et al., “Single nucleotide polymorphism discrimination assisted by improved base stacking hybridization using oligonucleotide microarrays,” Biotechniques. 35(2):300-8 (2003). |
Wang et al., “A novel thermo-induced self-bursting microcapsule with magnetic-targeting property,” Chemphyschem. 10(14):2405-9 (2009). |
Wang et al., “Digital karyotyping,” Proc Natl Acad Sci U S A. 99(25):16156-61 (2002). |
Ward et al., “Microfluidic flow focusing: drop size and scaling in pressure versus flow-rate-driven pumping,” Electrophoresis. 26(19):3716-24 (2005). |
Weaver, “Rapid clonal growth measurements at the single-cell level: gel microdroplets and flow cytometry,” Biotechnology (N Y). 9(9):873-877 (1991). |
Weigl et al., “Microfluidic Diffusion-Based Separation and Detection,” Science. 283(5400):346-7 (1999). |
Wesolowska et al., “Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemia, ” Leukemia. 25(6):1001-6 (2011). |
Whitesides et al., “Soft lithography in biology and biochemistry,” Annu Rev Biomed Eng. 3:335-73 (2001). |
Williams et al., “Amplification of complex gene libraries by emulsion PCR,” Nat Methods. 3(7):545-50 (2006). |
Wiseman et al., “Major histocompatibility complex genotyping with massively parallel pyrosequencing,” Nat Med. 15(11):1322-6 (2009). |
Wong et al., “Multiplexed Barcoded CRISPR-Cas9 Screening Enabled By CombiGEM,” Proc Natl Acad Sci U S A. 113(9):2544-9 (2016). |
Woo et al., “G/C-modified oligodeoxynucleotides with selective complementarity: synthesis and hybridization properties,” Nucleic Acids Res. 24(13):2470-5 (1996). |
Wood et al., “Targeted genome editing across species using ZFNs and TALENs,” Science. 333(6040):307 (2011). |
Xi et al., “New library construction method for single-cell genomes,” PLoS One. 12(7):e0181163 (2017). |
Xia et al., “Soft Lithography,” Ann Rev Mat Sci. 28:153-184 (1998). |
Xia et al., “Soft Lithography,” Angew Chem Int Ed Engl. 37(5):550-575 (1998). |
Xiao et al., “Determination of haplotypes from single DNA molecules: a method for single-molecule barcoding,” Hum Mutat. 28(9):913-21 (2007). |
Yamamoto et al., “Chemical modification of Ce(IV)/EDTA-based artificial restriction DNA cutter for versatile manipulation of double-stranded DNA,” Nucleic Acids Res. 35(7):e53 (2007). |
Yan et al., “Rapid one-step construction of hairpin RNA,” Biochem Biophys Res Commun. 383(4):464-8 (2009). |
Zeng et al., “High-performance single cell genetic analysis using microfluidic emulsion generator arrays,” Anal Chem. 82(8):3183-90 (2010). |
Zentner et al., “Surveying the epigenomic landscape, one base at a time,” Genome Biol. 13(10):250 (2012). |
Zhang et al., “Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription,” Nat Biotechnol. 29(2):149-53 (2011). |
Zhang et al., “Combinatorial marking of cells and organelles with reconstituted fluorescent proteins,” Cell. 119(1):137-144 (2004). |
Zhang et al., “Degradable disulfide core-cross-linked micelles as a drug delivery system prepared from vinyl functionalized nucleosides via the RAFT process,” Biomacromolecules. 9(11):3321-31 (2008). |
Zhang et al., “One-step fabrication of supramolecular microcapsules from microfluidic droplets,” Science. 335(6069):690-4 (2012). |
Zhang et al., “Reconstruction of DNA sequencing by hybridization,” Bioinformatics. 19(1):14-21 (2003). |
Zhang, Michael Yu, Thesis: “Genomics of inherited bone marrow failure and myelodysplasia,” Doctor of Philosophy in Molecular and Cellular Biology, University of Washington, 2015 (142 pages). |
Zhao et al., “Preparation of hemoglobin-loaded Nano-sized particles with porous structure as oxygen carriers,” Biomaterials. 28(7):1414-1422 (2007). |
Zheng et al., “Massively parallel digital transcriptional profiling of single cells,” Nat Commun. 8:14049 (2017). |
Zheng et al., “Haplotyping germline and cancer genomes with high-throughput linked-read sequencing,” Nat Biotechnol. 34(3):303-11 (2016). |
Zhou et al., “Development of an enzyme activity screening system for beta-glucosidase-displaying yeasts using calcium alginate micro-beads and flow sorting,” Appl Microbiol Biotechnol. 84: 375-382 (2009). |
Zhu et al., “Hydrogel Droplet Microfluidics for High-Throughput Single Molecule/Cell Analysis,” Accounts of Chemical Research. 50(1): 22-31 (2016). |
Zhu et al., “Reverse transcriptase template switching: a SMART approach for full-length cDNA library construction,” Biotechniques. 30(4):892-7 (2001). |
Zhu et al., “Synthesis and self-assembly of highly incompatible polybutadiene-poly(hexafluoropropylene oxide) diblock copolymers,” J Polymer Sci Part B: Polymer Phys. 43(24):3685-3694 (2005). |
Zimmermann et al., “Microscale production of hybridomas by hypo-osmolar electrofusion,” Hum Antibodies Hybridomas. 3(1):14-8 (1992). |
Zong et al., “Genome-Wide Detection of Single Nucleotide and Copy Number Variations of a Single Human Cell,” Science. 338(6114):1622-1626 (2012). |
Number | Date | Country | |
---|---|---|---|
20210362157 A1 | Nov 2021 | US |
Number | Date | Country | |
---|---|---|---|
62335870 | May 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16180356 | Nov 2018 | US |
Child | 17397146 | US | |
Parent | PCT/US2017/032520 | May 2017 | WO |
Child | 16180356 | US |